SCHEDULE 13G/A · 2026-11-05
FMR LLC discloses a 6.1% ownership stake in Travere Therapeutics, signaling confidence in the pharmaceutical company.
| Name | Travere Therapeutics, Inc. |
|---|---|
| CIK | 0001438533 |
| Tickers | TVTX |
| Exchanges | Nasdaq |
| Entity type | operating |
| Category | Large accelerated filer |
| SIC | 2834 Pharmaceutical Preparations |
| EIN | 262383102 |
| LEI | — |
| Fiscal year end | 1231 |
| State of incorporation | CA CA |
| Phone | 888-969-7879 |
| Website | — |
| Investor website | — |
| Owner org | 03 Life Sciences |
| Flags | — |
| Description | — |
| Insider transactions (issuer) | 1 |
| Insider transactions (owner) | 0 |
EDGAR has no company-logo API. Website field is shown when the filer provided one.
FMR LLC discloses a 6.1% ownership stake in Travere Therapeutics, signaling confidence in the pharmaceutical company.
Travere Therapeutics, Inc. shares insights into its Q3 2026 performance, highlighting its ongoing efforts in the pharmaceutical preparations sector.
1287 filing rows loaded from submissions recent; extra archives: CIK0001438533-submissions-001.json (286 filings, 2008-06-27 to 2015-10-07).
| Filed | Form | Document | Items | Accession | File no. | Film | Act | Size | XBRL | iXBRL |
|---|---|---|---|---|---|---|---|---|---|---|
| 2026-11-16 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000590 | 005-87088 | 261556980 | 34 | 171743 | |||
| 2026-11-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002862 | 005-87088 | 261526322 | 34 | 11840 | |||
| 2026-11-02 | 10-Q | 10-Q | 0001438533-26-000077 | 001-36257 | 261513145 | 34 | 9710627 | 1 | 1 | |
| 2026-11-02 | 8-K | 8-K | 2.02,9.01 | 0001438533-26-000074 | 001-36257 | 261512301 | 34 | 431979 | 1 | 1 |
| 2026-10-19 | 4 | xslF345X06/form4-10192026_041001.xml | 0001763494-26-000008 | 16848 | ||||||
| 2026-10-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-010273 | 001-36257 | 261463490 | 33 | 7225 | |||
| 2026-09-21 | 8-K | 8-K | 5.02,9.01 | 0001438533-26-000068 | 001-36257 | 261394058 | 34 | 505565 | 1 | 1 |
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010952.xml | 0001698262-26-000005 | 32919 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010901.xml | 0001789617-26-000004 | 42896 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010947.xml | 0001902368-26-000008 | 14736 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010948.xml | 0001283303-26-000010 | 14748 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010928.xml | 0001763494-26-000007 | 29302 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010929.xml | 0001943192-26-000006 | 14719 | ||||||
| 2026-09-17 | 4 | xslF345X06/form4-09182026_010916.xml | 0001882909-26-000004 | 20706 | ||||||
| 2026-09-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009642 | 001-36257 | 261387324 | 33 | 6485 | |||
| 2026-09-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009625 | 001-36257 | 261387215 | 33 | 6442 | |||
| 2026-09-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009577 | 001-36257 | 261384170 | 33 | 5723 | |||
| 2026-09-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009576 | 001-36257 | 261384168 | 33 | 5720 | |||
| 2026-09-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009566 | 001-36257 | 261384118 | 33 | 5748 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009523 | 001-36257 | 261381375 | 33 | 4960 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009521 | 001-36257 | 261381358 | 33 | 6465 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009520 | 001-36257 | 261381351 | 33 | 5584 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009513 | 001-36257 | 261381339 | 33 | 5011 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009510 | 001-36257 | 261381316 | 33 | 6324 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009503 | 001-36257 | 261381231 | 33 | 7025 | |||
| 2026-09-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009488 | 001-36257 | 261381085 | 33 | 6315 | |||
| 2026-09-11 | 4 | xslF345X06/form4-09112026_040911.xml | 0001506916-26-000004 | 18710 | ||||||
| 2026-09-10 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-009292 | 001-36257 | 261371568 | 33 | 4989 | |||
| 2026-09-03 | 4 | xslF345X06/form4-09032026_040908.xml | 0001943192-26-000005 | 5580 | ||||||
| 2026-08-19 | 4 | xslF345X06/form4-08192026_040801.xml | 0001123343-26-000010 | 20561 | ||||||
| 2026-08-18 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008327 | 001-36257 | 261291028 | 33 | 5750 | |||
| 2026-08-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-008242 | 001-36257 | 261287108 | 33 | 5032 | |||
| 2026-08-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-003621 | 005-87088 | 261277325 | 34 | 10815 | |||
| 2026-08-12 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000070858-26-000437 | 005-87088 | 261266605 | 34 | 171760 | |||
| 2026-08-07 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0000093751-26-000546 | 005-87088 | 261252355 | 34 | 8303 | |||
| 2026-08-06 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000315066-26-002183 | 005-87088 | 261247286 | 34 | 11922 | |||
| 2026-08-04 | 10-Q | 10-Q | 0001438533-26-000063 | 001-36257 | 261239645 | 34 | 10359358 | 1 | 1 | |
| 2026-08-04 | 8-K | 8-K | 2.02,9.01 | 0001438533-26-000062 | 001-36257 | 261238536 | 34 | 422621 | 1 | 1 |
| 2026-07-09 | 8-K | 8-K | 5.02 | 0001438533-26-000054 | 001-36257 | 261166355 | 34 | 152442 | 1 | 1 |
| 2026-06-22 | 4 | xslF345X06/form4-06222026_080607.xml | 0001902368-26-000007 | 5248 | ||||||
| 2026-06-17 | S-8 | S-8 | 0001438533-26-000052 | 333-296860 | 261099009 | 33 | 310224 | 1 | 1 | |
| 2026-06-16 | 4 | xslF345X06/form4-06162026_080644.xml | 0001376043-26-000010 | 9416 | ||||||
| 2026-06-16 | 4 | xslF345X06/form4-06162026_080649.xml | 0001680739-26-000014 | 8940 | ||||||
| 2026-06-16 | 8-K | 8-K | 5.02 | 0001438533-26-000048 | 001-36257 | 261095131 | 34 | 151806 | 1 | 1 |
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-005979 | 001-36257 | 261086508 | 33 | 8013 | |||
| 2026-06-12 | 144 | xsl144X01/primary_doc.xml | 0001376043-26-000007 | 001-36257 | 261085647 | 33 | 5347 | |||
| 2026-06-02 | 8-K | 8-K | 1.01,9.01 | 0001193125-26-252474 | 001-36257 | 261053585 | 34 | 155603 | 1 | 1 |
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050518.xml | 0001344381-26-000004 | 7711 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050515.xml | 0001454001-26-000002 | 7502 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050514.xml | 0001619622-26-000002 | 7504 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050512.xml | 0001477384-26-000008 | 7474 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050510.xml | 0001506916-26-000003 | 7501 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050508.xml | 0001123343-26-000004 | 7546 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050506.xml | 0001376043-26-000006 | 7662 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050504.xml | 0001517790-26-000002 | 7520 | ||||||
| 2026-05-21 | 4 | xslF345X06/form4-05212026_050501.xml | 0001680739-26-000012 | 7478 | ||||||
| 2026-05-21 | 8-K | 8-K | 5.02,5.07,9.01 | 0001438533-26-000046 | 001-36257 | 261008423 | 34 | 435242 | 1 | 1 |
| 2026-05-19 | 4 | xslF345X06/form4-05192026_040501.xml | 0001376043-26-000005 | 5357 | ||||||
| 2026-05-15 | 144 | xsl144X01/primary_doc.xml | 0001376043-26-000004 | 001-36257 | 26985015 | 33 | 4702 | |||
| 2026-05-15 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0001172661-26-002146 | 005-87088 | 26984135 | 34 | 10619 | |||
| 2026-05-11 | 8-K | 8-K | 1.01,2.03,3.02,8.01,9.01 | 0001193125-26-217100 | 001-36257 | 26964407 | 34 | 1612218 | 1 | 1 |
| 2026-05-07 | 424B5 | 424B5 | 0001193125-26-211968 | 333-281194 | 26953601 | 33 | 1675696 | 1 | 1 | |
| 2026-05-07 | 305B2 | 305B2 | 0001193125-26-211832 | 333-281194 | 26952955 | 33 | 264916 | |||
| 2026-05-07 | FWP | FWP | 0001193125-26-210121 | 333-281194 | 26950577 | 34 | 49324 | |||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080518.xml | 0001680739-26-000008 | 8942 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080516.xml | 0001506916-26-000001 | 9018 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080513.xml | 0001698262-26-000004 | 12414 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080511.xml | 0001283303-26-000009 | 19967 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080509.xml | 0001902368-26-000006 | 20007 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080506.xml | 0001789617-26-000003 | 12642 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080504.xml | 0001763494-26-000006 | 12372 | ||||||
| 2026-05-06 | 4 | xslF345X06/form4-05062026_080501.xml | 0001943192-26-000004 | 14496 | ||||||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004102 | 001-36257 | 26948191 | 33 | 8827 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004101 | 001-36257 | 26948187 | 33 | 11091 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004100 | 001-36257 | 26948181 | 33 | 8030 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003309 | 001-36257 | 26946315 | 33 | 6524 | |||
| 2026-05-06 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003306 | 001-36257 | 26946274 | 33 | 5304 | |||
| 2026-05-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-207099 | 001-36257 | 26945325 | 33 | 7717 | |||
| 2026-05-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-207083 | 001-36257 | 26945293 | 33 | 9736 | |||
| 2026-05-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-207080 | 001-36257 | 26945290 | 33 | 7003 | |||
| 2026-05-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-207078 | 001-36257 | 26945289 | 33 | 5661 | |||
| 2026-05-05 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-004082 | 001-36257 | 26944253 | 33 | 7261 | |||
| 2026-05-05 | 424B5 | 424B5 | 0001193125-26-206334 | 333-281194 | 26942910 | 33 | 1511236 | |||
| 2026-05-04 | 10-Q | 10-Q | 0001438533-26-000042 | 001-36257 | 26938576 | 34 | 8819412 | 1 | 1 | |
| 2026-05-04 | 4 | xslF345X06/form4-05042026_080519.xml | 0001680739-26-000007 | 8943 | ||||||
| 2026-05-04 | 8-K | 8-K | 2.02,9.01 | 0001438533-26-000041 | 001-36257 | 26937526 | 34 | 378543 | 1 | 1 |
| 2026-05-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003951 | 001-36257 | 26937435 | 33 | 9576 | |||
| 2026-05-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003950 | 001-36257 | 26937430 | 33 | 5027 | |||
| 2026-05-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003946 | 001-36257 | 26937401 | 33 | 6525 | |||
| 2026-05-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003899 | 001-36257 | 26932716 | 33 | 6510 | |||
| 2026-04-30 | SCHEDULE 13G | xslSCHEDULE_13G_X02/primary_doc.xml | 0002100119-26-001151 | 005-87088 | 26923159 | 34 | 7617 | |||
| 2026-04-23 | 4 | xslF345X06/form4-04232026_040401.xml | 0001698262-26-000003 | 5353 | ||||||
| 2026-04-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-003030 | 001-36257 | 26881782 | 33 | 5310 | |||
| 2026-04-16 | 4 | xslF345X06/form4-04162026_040407.xml | 0001123343-26-000002 | 9050 | ||||||
| 2026-04-16 | 4 | xslF345X06/form4-04162026_040405.xml | 0001680739-26-000005 | 24798 | ||||||
| 2026-04-16 | 4 | xslF345X06/form4-04162026_040403.xml | 0001882909-26-000003 | 16713 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010423.xml | 0001789617-26-000002 | 7395 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010440.xml | 0001698262-26-000002 | 5321 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010408.xml | 0001763494-26-000005 | 10901 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010431.xml | 0001283303-26-000008 | 24206 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010454.xml | 0001943192-26-000003 | 13140 | ||||||
| 2026-04-15 | 4 | xslF345X06/form4-04162026_010435.xml | 0001902368-26-000005 | 9232 | ||||||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002926 | 001-36257 | 26864351 | 33 | 7796 | |||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003482 | 001-36257 | 26864338 | 33 | 11091 | |||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003478 | 001-36257 | 26864295 | 33 | 8829 | |||
| 2026-04-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003477 | 001-36257 | 26864291 | 33 | 7280 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-155628 | 001-36257 | 26862319 | 33 | 9735 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-155560 | 001-36257 | 26862285 | 33 | 6327 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-155537 | 001-36257 | 26862276 | 33 | 5661 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-155495 | 001-36257 | 26862267 | 33 | 7717 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003429 | 001-36257 | 26861122 | 33 | 5028 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003426 | 001-36257 | 26861048 | 33 | 7309 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003425 | 001-36257 | 26861040 | 33 | 9575 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003420 | 001-36257 | 26860928 | 33 | 5760 | |||
| 2026-04-14 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003416 | 001-36257 | 26860833 | 33 | 6938 | |||
| 2026-04-14 | 8-K | 8-K | 8.01 | 0001438533-26-000032 | 001-36257 | 26858937 | 34 | 162651 | 1 | 1 |
| 2026-04-13 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-153378 | 001-36257 | 26858890 | 33 | 6333 | |||
| 2026-04-07 | 4 | xslF345X06/form4-04072026_100418.xml | 0001680739-26-000003 | 8957 | ||||||
| 2026-04-06 | ARS | ARS | 0001438533-26-000029 | 001-36257 | 26841296 | 34 | 53950898 | |||
| 2026-04-06 | DEFA14A | DEFA14A | 0001438533-26-000028 | 001-36257 | 26841270 | 34 | 63962 | |||
| 2026-04-06 | DEF 14A | DEF 14A | 0001438533-26-000027 | 001-36257 | 26841245 | 34 | 4133291 | 1 | 1 | |
| 2026-04-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003230 | 001-36257 | 26841209 | 33 | 5007 | |||
| 2026-04-02 | 4 | xslF345X06/form4-04022026_050410.xml | 0001763494-26-000004 | 11234 | ||||||
| 2026-04-02 | 4 | xslF345X06/form4-04022026_050408.xml | 0001283303-26-000007 | 9015 | ||||||
| 2026-04-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-002715 | 001-36257 | 26828311 | 33 | 7074 | |||
| 2026-04-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-003118 | 001-36257 | 26828167 | 33 | 8818 | |||
| 2026-03-27 | SCHEDULE 13G/A | xslSCHEDULE_13G_X02/primary_doc.xml | 0000102909-26-002431 | 005-87088 | 26804819 | 34 | 7382 | |||
| 2026-03-18 | 4 | xslF345X06/form4-03182026_040301.xml | 0001283303-26-000006 | 9377 | ||||||
| 2026-03-16 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-002635 | 001-36257 | 26757026 | 33 | 8062 | |||
| 2026-02-24 | 4 | xslF345X05/form4-02242026_040201.xml | 0001763494-26-000003 | 9108 | ||||||
| 2026-02-20 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-001307 | 001-36257 | 26660901 | 33 | 6409 | |||
| 2026-02-19 | 10-K | 10-K | 0001438533-26-000014 | 001-36257 | 26655251 | 34 | 14226087 | 1 | 1 | |
| 2026-02-19 | 4 | xslF345X05/form4-02192026_040201.xml | 0001283303-26-000005 | 11204 | ||||||
| 2026-02-19 | 8-K | 8-K | 2.02,9.01 | 0001438533-26-000013 | 001-36257 | 26654324 | 34 | 375630 | 1 | 1 |
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-26-001227 | 005-87088 | 26645053 | 34 | 10720 | |||
| 2026-02-17 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-001339 | 001-36257 | 26642150 | 33 | 7306 | |||
| 2026-02-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-26-054520 | 005-87088 | 26640550 | 34 | 10985 | |||
| 2026-02-13 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-26-049707 | 005-87088 | 26628731 | 34 | 205550 | |||
| 2026-02-09 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000093751-26-000092 | 005-87088 | 26609683 | 34 | 8195 | |||
| 2026-02-05 | 4 | xslF345X05/form4-02052026_040203.xml | 0001902368-26-000004 | 7453 | ||||||
| 2026-02-05 | 4 | xslF345X05/form4-02052026_040201.xml | 0001943192-26-000002 | 7099 | ||||||
| 2026-02-05 | 4 | xslF345X05/form4-02052026_040205.xml | 0001283303-26-000003 | 7459 | ||||||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000918 | 001-36257 | 26598233 | 33 | 6554 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000917 | 001-36257 | 26598219 | 33 | 8028 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000904 | 001-36257 | 26598064 | 33 | 6565 | |||
| 2026-02-04 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-036557 | 001-36257 | 26595905 | 33 | 5634 | |||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-036479 | 001-36257 | 26595902 | 33 | 5612 | |||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-036474 | 001-36257 | 26595897 | 33 | 6967 | |||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-036459 | 001-36257 | 26595873 | 33 | 5659 | |||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-036456 | 001-36257 | 26595848 | 33 | 6977 | |||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090212.xml | 0001763494-26-000002 | 11451 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090210.xml | 0001902368-26-000003 | 9456 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090208.xml | 0001943192-26-000001 | 9474 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090207.xml | 0001789617-26-000001 | 9463 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090205.xml | 0001698262-26-000001 | 9236 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090201.xml | 0001882909-26-000001 | 9436 | ||||||
| 2026-02-03 | 4 | xslF345X05/form4-02032026_090203.xml | 0001283303-26-000002 | 9453 | ||||||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000570 | 001-36257 | 26590954 | 33 | 5887 | |||
| 2026-02-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000560 | 001-36257 | 26590520 | 33 | 5306 | |||
| 2026-01-27 | 4 | xslF345X05/form4-01282026_010144.xml | 0001763494-26-000001 | 14594 | ||||||
| 2026-01-27 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000458 | 001-36257 | 26565461 | 33 | 6515 | |||
| 2026-01-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-26-000432 | 001-36257 | 26556582 | 33 | 5945 | |||
| 2026-01-21 | 4 | xslF345X05/form4-01212026_040109.xml | 0001283303-26-000001 | 9495 | ||||||
| 2026-01-20 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000541 | 001-36257 | 26542804 | 33 | 5041 | |||
| 2026-01-13 | 8-K | 8-K | 8.01 | 0001438533-26-000005 | 001-36257 | 26530461 | 34 | 161495 | 1 | 1 |
| 2026-01-12 | 8-K | 8-K | 2.02,9.01 | 0001438533-26-000003 | 001-36257 | 26527630 | 34 | 222475 | 1 | 1 |
| 2026-01-08 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0000315066-26-000051 | 005-87088 | 26517684 | 34 | 11732 | |||
| 2026-01-07 | 4 | xslF345X05/form4-01072026_040106.xml | 0001902368-26-000002 | 7254 | ||||||
| 2026-01-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-26-000175 | 001-36257 | 26511476 | 33 | 6526 | |||
| 2026-01-05 | 144 | xsl144X01/primary_doc.xml | 0001193125-26-003062 | 001-36257 | 26508904 | 33 | 5629 | |||
| 2025-12-29 | 4 | xslF345X05/form4-12302025_021236.xml | 0001789617-25-000009 | 5083 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12302025_021233.xml | 0001698262-25-000005 | 9638 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12302025_021222.xml | 0001902368-25-000005 | 9301 | ||||||
| 2025-12-29 | 4 | xslF345X05/form4-12302025_011208.xml | 0001882909-25-000008 | 5057 | ||||||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010715 | 001-36257 | 251604366 | 33 | 5267 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010713 | 001-36257 | 251604354 | 33 | 9116 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007920 | 001-36257 | 251602892 | 33 | 6469 | |||
| 2025-12-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-007916 | 001-36257 | 251602709 | 33 | 4663 | |||
| 2025-12-16 | 4 | xslF345X05/form4-12162025_091205.xml | 0001882909-25-000006 | 5057 | ||||||
| 2025-12-15 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-010276 | 001-36257 | 251571584 | 33 | 5758 | |||
| 2025-12-03 | 4 | xslF345X05/form4-12032025_041209.xml | 0001943192-25-000005 | 9313 | ||||||
| 2025-12-01 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-009511 | 001-36257 | 251539728 | 33 | 6557 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-005160 | 005-87088 | 251488689 | 34 | 10911 | |||
| 2025-11-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000318 | 005-87088 | 251483736 | 34 | 9749 | |||
| 2025-11-06 | 4 | xslF345X05/form4-11062025_041101.xml | 0001882909-25-000004 | 23860 | ||||||
| 2025-11-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-008434 | 001-36257 | 251449218 | 33 | 9122 | |||
| 2025-11-04 | 4 | xslF345X05/form4-11042025_041110.xml | 0001376043-25-000004 | 12855 | ||||||
| 2025-11-04 | 4 | xslF345X05/form4-11042025_041108.xml | 0001789617-25-000007 | 6895 | ||||||
| 2025-10-31 | 144 | xsl144X01/primary_doc.xml | 0001957799-25-000224 | 001-36257 | 251440504 | 33 | 4679 | |||
| 2025-10-31 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006629 | 001-36257 | 251440159 | 33 | 6908 | |||
| 2025-10-30 | 10-Q | 10-Q | 0001438533-25-000056 | 001-36257 | 251436637 | 34 | 9078566 | 1 | 1 | |
| 2025-10-30 | 4 | xslF345X05/form4-10302025_041004.xml | 0001763494-25-000005 | 14599 | ||||||
| 2025-10-30 | 4 | xslF345X05/form4-10302025_041001.xml | 0001789617-25-000006 | 5083 | ||||||
| 2025-10-30 | 8-K | 8-K | 2.02,9.01 | 0001438533-25-000055 | 001-36257 | 251435503 | 34 | 426369 | 1 | 1 |
| 2025-10-29 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006603 | 001-36257 | 251430368 | 33 | 5209 | |||
| 2025-10-28 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006592 | 001-36257 | 251425650 | 33 | 4601 | |||
| 2025-10-28 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-006585 | 001-36257 | 251423299 | 33 | 5200 | |||
| 2025-10-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001193125-25-238357 | 005-87088 | 251390038 | 34 | 303513 | |||
| 2025-09-24 | 4 | xslF345X05/form4-09242025_040905.xml | 0001789617-25-000004 | 5180 | ||||||
| 2025-09-24 | 4 | xslF345X05/form4-09242025_040903.xml | 0001283303-25-000005 | 9098 | ||||||
| 2025-09-22 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-007388 | 001-36257 | 251330034 | 33 | 5042 | |||
| 2025-09-10 | 8-K | 8-K | 8.01 | 0001438533-25-000049 | 001-36257 | 251304655 | 34 | 161635 | 1 | 1 |
| 2025-09-05 | 4 | xslF345X05/form4-09052025_040901.xml | 0001415889-25-023786 | 7272 | ||||||
| 2025-08-28 | 4 | xslF345X05/form4-08282025_040801.xml | 0001415889-25-023209 | 5272 | ||||||
| 2025-08-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-003635 | 005-87088 | 251223558 | 34 | 10867 | |||
| 2025-08-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000194 | 005-87088 | 251192300 | 34 | 9749 | |||
| 2025-08-06 | 10-Q | 10-Q | 0001438533-25-000046 | 001-36257 | 251190679 | 34 | 9025137 | 1 | 1 | |
| 2025-08-06 | 8-K | 8-K | 2.02,9.01 | 0001438533-25-000045 | 001-36257 | 251189521 | 34 | 418149 | 1 | 1 |
| 2025-07-29 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-001051 | 005-87088 | 251160687 | 34 | 6424 | |||
| 2025-07-02 | 4 | xslF345X05/form4-07022025_090753.xml | 0001415889-25-019108 | 5261 | ||||||
| 2025-06-17 | S-8 | S-8 | 0001438533-25-000038 | 333-288114 | 251054253 | 33 | 307980 | 1 | 1 | |
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070518.xml | 0001415889-25-013504 | 7573 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070517.xml | 0001415889-25-013503 | 7353 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070515.xml | 0001415889-25-013502 | 7302 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070513.xml | 0001415889-25-013501 | 7336 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070511.xml | 0001415889-25-013500 | 7331 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070509.xml | 0001415889-25-013499 | 7404 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070507.xml | 0001415889-25-013498 | 7412 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070505.xml | 0001415889-25-013497 | 7380 | ||||||
| 2025-05-16 | 4 | xslF345X05/form4-05162025_070503.xml | 0001415889-25-013496 | 7353 | ||||||
| 2025-05-16 | 8-K | 8-K | 5.02,5.07,9.01 | 0001438533-25-000034 | 001-36257 | 25959397 | 34 | 440793 | 1 | 1 |
| 2025-05-15 | 8-K | 8-K | 8.01 | 0001438533-25-000032 | 001-36257 | 25954014 | 34 | 168932 | 1 | 1 |
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002216 | 005-87088 | 25951813 | 34 | 10867 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-002075 | 005-87088 | 25949902 | 34 | 14836 | |||
| 2025-05-15 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-071930 | 005-87088 | 25948463 | 34 | 244190 | |||
| 2025-05-14 | SCHEDULE 13G | xslSCHEDULE_13G_X01/primary_doc.xml | 0001274173-25-000125 | 005-87088 | 25943766 | 34 | 9619 | |||
| 2025-05-05 | 4 | xslF345X05/form4-05062025_010528.xml | 0001415889-25-012061 | 9760 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05062025_010542.xml | 0001415889-25-012058 | 9474 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05062025_010504.xml | 0001415889-25-012057 | 9749 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05062025_010518.xml | 0001415889-25-012056 | 9523 | ||||||
| 2025-05-05 | 4 | xslF345X05/form4-05062025_010531.xml | 0001415889-25-012054 | 9449 | ||||||
| 2025-05-05 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-063806 | 001-36257 | 25914718 | 33 | 6357 | |||
| 2025-05-05 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-063804 | 001-36257 | 25914711 | 33 | 7021 | |||
| 2025-05-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002858 | 001-36257 | 25911677 | 33 | 5251 | |||
| 2025-05-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002857 | 001-36257 | 25911622 | 33 | 5247 | |||
| 2025-05-05 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-002850 | 001-36257 | 25911399 | 33 | 5307 | |||
| 2025-05-01 | 8-K/A | 8-K/A | 2.02,9.01 | 0001438533-25-000030 | 001-36257 | 25904439 | 34 | 378491 | 1 | 1 |
| 2025-05-01 | 10-Q | 10-Q | 0001438533-25-000026 | 001-36257 | 25903982 | 34 | 8249747 | 1 | 1 | |
| 2025-05-01 | 8-K | 8-K | 2.01,9.01 | 0001438533-25-000025 | 001-36257 | 25903009 | 34 | 377364 | 1 | 1 |
| 2025-04-30 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000623 | 005-87088 | 25892281 | 34 | 6421 | |||
| 2025-04-30 | 8-K | 8-K | 8.01 | 0001438533-25-000020 | 001-36257 | 25889772 | 34 | 166154 | 1 | 1 |
| 2025-04-17 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001576419-25-000661 | 005-87088 | 25844617 | 34 | 11257 | |||
| 2025-04-14 | 4 | xslF345X05/form4-04142025_100426.xml | 0001415889-25-010643 | 5442 | ||||||
| 2025-04-11 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-053412 | 001-36257 | 25833874 | 33 | 6331 | |||
| 2025-04-01 | ARS | ARS | 0001438533-25-000018 | 001-36257 | 25799696 | 34 | 1900387 | |||
| 2025-04-01 | DEFA14A | DEFA14A | 0001438533-25-000017 | 001-36257 | 25799672 | 34 | 130835 | |||
| 2025-04-01 | DEF 14A | DEF 14A | 0001438533-25-000016 | 001-36257 | 25799649 | 34 | 4134529 | 1 | 1 | |
| 2025-03-17 | 8-K | 8-K | 8.01 | 0001438533-25-000012 | 001-36257 | 25745381 | 34 | 168761 | 1 | 1 |
| 2025-02-21 | 10-K | 10-K | 0001438533-25-000010 | 001-36257 | 25648184 | 34 | 14568109 | 1 | 1 | |
| 2025-02-20 | 8-K | 8-K | 2.02,9.01 | 0001438533-25-000008 | 001-36257 | 25645205 | 34 | 387987 | 1 | 1 |
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-001271 | 005-87088 | 25631059 | 34 | 10884 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000902664-25-001022 | 005-87088 | 25628445 | 34 | 9136 | |||
| 2025-02-14 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0001172661-25-000906 | 005-87088 | 25623775 | 34 | 14656 | |||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020257.xml | 0001415889-25-003824 | 9530 | ||||||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020224.xml | 0001415889-25-003823 | 9468 | ||||||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020258.xml | 0001415889-25-003822 | 27009 | ||||||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020229.xml | 0001415889-25-003821 | 11475 | ||||||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020239.xml | 0001415889-25-003820 | 5044 | ||||||
| 2025-02-12 | 4 | xslF345X05/form4-02132025_020211.xml | 0001415889-25-003819 | 9753 | ||||||
| 2025-02-12 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-019188 | 001-36257 | 25616723 | 33 | 7016 | |||
| 2025-02-12 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-019185 | 001-36257 | 25616711 | 33 | 7676 | |||
| 2025-02-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000907 | 001-36257 | 25613148 | 33 | 5940 | |||
| 2025-02-12 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000901 | 001-36257 | 25612736 | 33 | 5896 | |||
| 2025-02-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000746 | 001-36257 | 25609828 | 33 | 9514 | |||
| 2025-02-11 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000744 | 001-36257 | 25609722 | 33 | 7134 | |||
| 2025-02-11 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000867 | 001-36257 | 25608438 | 33 | 5812 | |||
| 2025-02-11 | 8-K | 8-K | 8.01 | 0001438533-25-000004 | 001-36257 | 25607660 | 34 | 164728 | 1 | 1 |
| 2025-02-10 | 4 | xslF345X05/form4-02102025_110214.xml | 0001415889-25-003529 | 8882 | ||||||
| 2025-02-07 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000950170-25-015862 | 005-87088 | 25599328 | 34 | 405272 | |||
| 2025-02-06 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000648 | 001-36257 | 25597685 | 33 | 5783 | |||
| 2025-02-05 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0002012383-25-001251 | 005-87088 | 25592255 | 34 | 12286 | |||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080224.xml | 0001415889-25-003067 | 9239 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080220.xml | 0001415889-25-003066 | 9177 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080216.xml | 0001415889-25-003065 | 9574 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080213.xml | 0001415889-25-003064 | 11296 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080209.xml | 0001415889-25-003063 | 9469 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080206.xml | 0001415889-25-003062 | 9478 | ||||||
| 2025-02-04 | 4 | xslF345X05/form4-02042025_080201.xml | 0001415889-25-003061 | 9442 | ||||||
| 2025-02-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000601 | 001-36257 | 25588260 | 33 | 7281 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-012658 | 001-36257 | 25584728 | 33 | 5643 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-012655 | 001-36257 | 25584725 | 33 | 5663 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-012650 | 001-36257 | 25584715 | 33 | 6969 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0000950170-25-012649 | 001-36257 | 25584712 | 33 | 5633 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000613 | 001-36257 | 25581479 | 33 | 5256 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000603 | 001-36257 | 25581166 | 33 | 5321 | |||
| 2025-02-03 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000596 | 001-36257 | 25581049 | 33 | 5303 | |||
| 2025-01-31 | SCHEDULE 13G/A | xslSCHEDULE_13G_X01/primary_doc.xml | 0000932471-25-000267 | 005-87088 | 25576421 | 34 | 6479 | |||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010159.xml | 0001415889-25-002008 | 5394 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010157.xml | 0001415889-25-002006 | 5162 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010150.xml | 0001415889-25-002004 | 5331 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010152.xml | 0001415889-25-002003 | 8884 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010141.xml | 0001415889-25-002001 | 5441 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010121.xml | 0001415889-25-001999 | 5450 | ||||||
| 2025-01-23 | 4 | xslF345X05/form4-01242025_010158.xml | 0001415889-25-001997 | 5414 | ||||||
| 2025-01-23 | 144 | xsl144X01/primary_doc.xml | 0001950047-25-000396 | 001-36257 | 25550284 | 33 | 5029 | |||
| 2025-01-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000412 | 001-36257 | 25544221 | 33 | 4617 | |||
| 2025-01-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000411 | 001-36257 | 25544173 | 33 | 4613 | |||
| 2025-01-22 | 144 | xsl144X01/primary_doc.xml | 0001959173-25-000402 | 001-36257 | 25544068 | 33 | 4661 | |||
| 2025-01-13 | 8-K | 8-K | 2.02,9.01 | 0001438533-25-000002 | 001-36257 | 25524805 | 34 | 232985 | 1 | 1 |
| 2025-01-06 | 4 | xslF345X05/form4-01072025_120158.xml | 0001415889-25-000899 | 7267 | ||||||
| 2024-12-27 | 4 | xslF345X05/form4-12282024_121201.xml | 0001415889-24-030210 | 9190 | ||||||
| 2024-12-26 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-010073 | 001-36257 | 241581224 | 33 | 5771 | |||
| 2024-11-25 | 4 | xslF345X05/form4-11262024_021145.xml | 0001415889-24-027672 | 9297 | ||||||
| 2024-11-25 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001739 | 001-36257 | 241497531 | 33 | 4455 | |||
| 2024-11-14 | SC 13G/A | armistice-tvtx093024a3.htm | 0001172661-24-005319 | 005-87088 | 241464249 | 34 | 90950 | |||
| 2024-11-14 | SC 13G | TRAVERE THERAPEUTICS, INC. | 0000902664-24-006574 | 005-87088 | 241459662 | 34 | 50629 | |||
| 2024-11-14 | SC 13G/A | deeptrack-tvtx093024a3.htm | 0001172661-24-004777 | 005-87088 | 241457911 | 34 | 103346 | |||
| 2024-11-12 | SC 13G/A | UnitedStates_13G__TravereThe.txt | 0000932471-24-001276 | 005-87088 | 241450288 | 34 | 6767 | |||
| 2024-11-08 | SC 13G/A | MS AMENDMENT | 0000895421-24-000641 | 005-87088 | 241441514 | 34 | 13053 | |||
| 2024-11-08 | 8-K | 8-K | 8.01,9.01 | 0001193125-24-254153 | 001-36257 | 241440731 | 34 | 510907 | 1 | 1 |
| 2024-11-08 | 424B5 | 424B5 | 0001193125-24-254147 | 333-281194 | 241440675 | 33 | 729074 | 1 | 1 | |
| 2024-11-07 | 424B5 | 424B5 | 0001193125-24-253102 | 333-281194 | 241435360 | 33 | 575305 | |||
| 2024-11-04 | SC 13G/A | UnitedStates_13G__TravereThe.txt | 0000932471-24-000711 | 005-87088 | 241422463 | 34 | 5811 | |||
| 2024-10-31 | 424B5 | 424B5 | 0001438533-24-000050 | 333-281194 | 241412611 | 33 | 540377 | 1 | 1 | |
| 2024-10-31 | 10-Q | 10-Q | 0001438533-24-000048 | 001-36257 | 241412601 | 34 | 9989224 | 1 | 1 | |
| 2024-10-31 | 8-K | 8-K | 2.02,9.01 | 0001438533-24-000046 | 001-36257 | 241412531 | 34 | 421489 | 1 | 1 |
| 2024-10-18 | SC 13G/A | Travere_Therapeutics_Inc.htm | 0000093751-24-000882 | 005-87088 | 241379476 | 34 | 56157 | |||
| 2024-10-04 | 4 | xslF345X05/form4-10042024_111048.xml | 0001415889-24-024795 | 11209 | ||||||
| 2024-10-04 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007584 | 001-36257 | 241355171 | 33 | 5034 | |||
| 2024-09-30 | 4 | xslF345X05/form4-10012024_121008.xml | 0001415889-24-024117 | 9248 | ||||||
| 2024-09-30 | 144 | xsl144X01/primary_doc.xml | 0001950047-24-007453 | 001-36257 | 241339780 | 33 | 5005 | |||
| 2024-09-26 | 8-K | 8-K | 8.01 | 0001438533-24-000038 | 001-36257 | 241328810 | 34 | 164488 | 1 | 1 |
| 2024-09-11 | 144 | xsl144X01/primary_doc.xml | 0001972362-24-001327 | 001-36257 | 241293510 | 33 | 4455 | |||
| 2024-09-10 | 4 | xslF345X05/form4-09102024_040901.xml | 0001415889-24-023128 | 5244 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090913.xml | 0001415889-24-023096 | 7395 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090911.xml | 0001415889-24-023095 | 7103 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090909.xml | 0001415889-24-023094 | 7123 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090907.xml | 0001415889-24-023093 | 7390 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090904.xml | 0001415889-24-023092 | 7630 | ||||||
| 2024-09-09 | 4 | xslF345X05/form4-09092024_090901.xml | 0001415889-24-023091 | 7408 | ||||||
| 2024-09-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006328 | 001-36257 | 241286300 | 33 | 4621 | |||
| 2024-09-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006326 | 001-36257 | 241286227 | 33 | 4662 | |||
| 2024-09-09 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-006325 | 001-36257 | 241286225 | 33 | 4619 | |||
| 2024-09-06 | 8-K | 8-K | 8.01,9.01 | 0001438533-24-000035 | 001-36257 | 241282376 | 34 | 175857 | 1 | 1 |
| 2024-09-05 | 4 | xslF345X05/form4-09052024_090901.xml | 0001415889-24-022992 | 5450 | ||||||
| 2024-08-01 | S-3ASR | S-3ASR | 0001193125-24-191647 | 333-281194 | 241167996 | 33 | 1198479 | 1 | 1 | |
| 2024-08-01 | 10-Q | 10-Q | 0001438533-24-000031 | 001-36257 | 241167408 | 34 | 9387392 | 1 | 1 | |
| 2024-08-01 | 8-K | 8-K | 2.02,9.01 | 0001438533-24-000030 | 001-36257 | 241166565 | 34 | 404200 | 1 | 1 |
| 2024-06-14 | S-8 | S-8 | 0001438533-24-000025 | 333-280213 | 241044727 | 33 | 170380 | |||
| 2024-05-13 | 8-K | 8-K | 5.02,5.07,9.01 | 0001438533-24-000022 | 001-36257 | 24938982 | 34 | 443937 | 1 | 1 |
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040553.xml | 0001415889-24-012851 | 7351 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040555.xml | 0001415889-24-012852 | 7571 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040541.xml | 0001415889-24-012849 | 7334 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040548.xml | 0001415889-24-012850 | 7300 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040536.xml | 0001415889-24-012848 | 7329 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040530.xml | 0001415889-24-012847 | 7402 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040522.xml | 0001415889-24-012846 | 7410 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040513.xml | 0001415889-24-012845 | 7369 | ||||||
| 2024-05-10 | 4 | xslF345X05/form4-05102024_040510.xml | 0001415889-24-012844 | 7351 | ||||||
| 2024-05-06 | 10-Q | 10-Q | 0001438533-24-000020 | 001-36257 | 24918271 | 34 | 9242996 | 1 | 1 | |
| 2024-05-06 | 8-K | 8-K | 2.02,9.01 | 0001438533-24-000019 | 001-36257 | 24917479 | 34 | 373317 | 1 | 1 |
| 2024-05-01 | SC 13G | rocksprings-tvtx042524.htm | 0001172661-24-001968 | 005-87088 | 24903122 | 34 | 110485 | |||
| 2024-04-24 | 8-K | 8-K | 8.01,9.01 | 0001438533-24-000016 | 001-36257 | 24870544 | 34 | 168146 | 1 | 1 |
| 2024-04-12 | 4 | xslF345X05/form4-04122024_040401.xml | 0001415889-24-010754 | 5446 | ||||||
| 2024-03-27 | ARS | ARS | 0001438533-24-000014 | 001-36257 | 24791369 | 34 | 2734615 | |||
| 2024-03-27 | DEFA14A | DEFA14A | 0001438533-24-000013 | 001-36257 | 24791326 | 34 | 129852 | |||
| 2024-03-27 | DEF 14A | DEF 14A | 0001438533-24-000012 | 001-36257 | 24791275 | 34 | 2482486 | 1 | 1 | |
| 2024-02-23 | 8-K | 8-K | 8.01,9.01 | 0001438533-24-000007 | 001-36257 | 24671122 | 34 | 170380 | 1 | 1 |
| 2024-02-20 | 10-K | 10-K | 0001438533-24-000005 | 001-36257 | 24650861 | 34 | 15448727 | 1 | 1 | |
| 2024-02-15 | 8-K | 8-K | 2.02,9.01 | 0001438533-24-000003 | 001-36257 | 24643780 | 34 | 382603 | 1 | 1 |
| 2024-02-14 | SC 13G/A | armistice-tvtx123123a2.htm | 0001172661-24-001245 | 005-87088 | 24636188 | 34 | 90923 | |||
| 2024-02-14 | SC 13G/A | deeptrack-tvtx123123a2.htm | 0001172661-24-000946 | 005-87088 | 24632745 | 34 | 105162 | |||
| 2024-02-14 | SC 13G/A | SC 13G/A | 0001193125-24-034915 | 005-87088 | 24632080 | 34 | 106043 | |||
| 2024-02-13 | SC 13G/A | SCHEDULE 13G/A | 0001104659-24-022126 | 005-87088 | 24629830 | 34 | 13269 | |||
| 2024-02-12 | SC 13G/A | JHG PLC OWNS <5% | 0001274173-24-000013 | 005-87088 | 24619338 | 34 | 10329 | |||
| 2024-02-09 | SC 13G | MS INITIAL | 0000895421-24-000110 | 005-87088 | 24612818 | 34 | 12903 | |||
| 2024-02-07 | SC 13G/A | TRAVERE THERAPEUTICS, INC. | 0000902664-24-001160 | 005-87088 | 24602178 | 34 | 101283 | |||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040236.xml | 0001415889-24-002285 | 11230 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040225.xml | 0001415889-24-002284 | 11271 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040202.xml | 0001415889-24-002279 | 11333 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040213.xml | 0001415889-24-002283 | 11210 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040211.xml | 0001415889-24-002282 | 9853 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040208.xml | 0001415889-24-002281 | 9460 | ||||||
| 2024-02-02 | 4 | xslF345X05/form4-02022024_040206.xml | 0001415889-24-002280 | 9863 | ||||||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009992 | 001-36257 | 24588654 | 33 | 6318 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009991 | 001-36257 | 24588653 | 33 | 6241 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009990 | 001-36257 | 24588651 | 33 | 5642 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0000950170-24-009988 | 001-36257 | 24588648 | 33 | 6325 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000557 | 001-36257 | 24585866 | 33 | 5317 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000553 | 001-36257 | 24585664 | 33 | 5226 | |||
| 2024-02-01 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000539 | 001-36257 | 24585290 | 33 | 5299 | |||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040109.xml | 0001415889-24-001801 | 5120 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040107.xml | 0001415889-24-001799 | 5133 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040102.xml | 0001415889-24-001798 | 5449 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040111.xml | 0001415889-24-001800 | 5413 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040102.xml | 0001415889-24-001796 | 5413 | ||||||
| 2024-01-25 | 4 | xslF345X05/form4-01252024_040105.xml | 0001415889-24-001797 | 5439 | ||||||
| 2024-01-25 | SC 13G/A | Travere_Therap_Inc.txt | 0000093751-24-000210 | 005-87088 | 24559144 | 34 | 10603 | |||
| 2024-01-24 | SC 13G/A | us89422g1076_012324.txt | 0001086364-24-002023 | 005-87088 | 24554615 | 34 | 13891 | |||
| 2024-01-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000418 | 001-36257 | 24551811 | 33 | 4680 | |||
| 2024-01-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000411 | 001-36257 | 24550949 | 33 | 4624 | |||
| 2024-01-23 | 144 | xsl144X01/primary_doc.xml | 0001959173-24-000410 | 001-36257 | 24550939 | 33 | 4670 | |||
| 2024-01-08 | 8-K | FORM 8-K | 2.02,9.01 | 0001193125-24-003866 | 001-36257 | 24518303 | 34 | 197906 | 1 | 1 |
| 2024-01-05 | 4 | FORM 4 SUBMISSION | 0001209191-24-001005 | 7341 | ||||||
| 2023-12-04 | 8-K | 8-K | 2.05,8.01,9.01 | 0001438533-23-000050 | 001-36257 | 231463119 | 34 | 176818 | 1 | 1 |
| 2023-11-07 | 10-Q | 10-Q | 0001438533-23-000048 | 001-36257 | 231385081 | 34 | 9277552 | 1 | 1 | |
| 2023-11-07 | 8-K | 8-K | 2.02,9.01 | 0001438533-23-000046 | 001-36257 | 231383610 | 34 | 428769 | 1 | 1 |
| 2023-10-06 | SC 13G/A | us89422g1076_100523.txt | 0001306550-23-010082 | 005-87088 | 231313921 | 34 | 13801 | |||
| 2023-10-04 | 4 | FORM 4 SUBMISSION | 0001209191-23-051885 | 5638 | ||||||
| 2023-09-21 | 8-K | 8-K | 8.01 | 0001193125-23-239098 | 001-36257 | 231267744 | 34 | 323517 | 1 | 1 |
One latest value per concept from companyfacts (619 concepts). Full history stays in the JSON.
| Taxonomy | Tag | Label | Unit | Value | Start | End | FY | FP | Form | Filed | Accn |
|---|---|---|---|---|---|---|---|---|---|---|---|
| dei | EntityCommonStockSharesOutstanding | Entity Common Stock, Shares Outstanding | shares | 95.99M | 2026-10-28 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| dei | EntityNumberOfEmployees | Entity Number of Employees | Employee | 135 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001628280-16-020847 | |
| dei | EntityPublicFloat | Entity Public Float | USD | 1.31B | 2025-06-30 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| ecd | CoSelectedMeasureAmt | CoSelectedMeasureAmt | USD | 410.46M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | NonPeoNeoAvgCompActuallyPaidAmt | NonPeoNeoAvgCompActuallyPaidAmt | USD | 6.03M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | NonPeoNeoAvgTotalCompAmt | NonPeoNeoAvgTotalCompAmt | USD | 2.45M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | PeerGroupTotalShareholderRtnAmt | PeerGroupTotalShareholderRtnAmt | USD | 124.75 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | PeoActuallyPaidCompAmt | PeoActuallyPaidCompAmt | USD | 24.50M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | PeoTotalCompAmt | PeoTotalCompAmt | USD | 8.46M | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ecd | TotalShareholderRtnAmt | TotalShareholderRtnAmt | USD | 140.19 | 2025-01-01 | 2025-12-31 | DEF 14A | 2026-04-06 | 0001438533-26-000027 | ||
| ffd | NetFeeAmt | NetFeeAmt | USD | 72,502.5 | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| ffd | NrrtvMaxAggtOfferingPric | NrrtvMaxAggtOfferingPric | USD | 525.00M | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| ffd | TtlFeeAmt | TtlFeeAmt | USD | 72,502.5 | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| ffd | TtlOfferingAmt | TtlOfferingAmt | USD | 525.00M | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| ffd | TtlOffsetAmt | TtlOffsetAmt | USD | 0 | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| ffd | TtlPrevslyPdAmt | TtlPrevslyPdAmt | USD | 0 | 2026-05-07 | 424B5 | 2026-05-07 | 0001193125-26-211968 | |||
| invest | InvestmentInterestRate | Investment Interest Rate | pure | 0.12 | 2012-02-02 | 2012-02-03 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | AccountsPayableAndAccruedLiabilities | Accounts Payable and Accrued Liabilities (Deprecated 2009-01-31) | USD | 2,000 | 2012-02-29 | 2011 | FY | 10-K | 2012-05-24 | 0001225279-12-000073 | |
| us-gaap | AccountsPayableCurrent | Accounts Payable, Current | USD | 15.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AccountsPayableRelatedPartiesCurrent | Accounts Payable, Related Parties, Current | USD | 10,000 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | AccountsPayableTrade | Accounts Payable, Trade (Deprecated 2009-01-31) | USD | 750 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 | |
| us-gaap | AccountsPayableTradeCurrent | Accounts Payable, Trade, Current | USD | 750 | 2012-11-30 | 2012 | Q3 | 10-Q | 2013-03-06 | 0001193805-13-000588 | |
| us-gaap | AccountsReceivableNetCurrent | Accounts Receivable, after Allowance for Credit Loss, Current | USD | 107.53M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AccretionAmortizationOfDiscountsAndPremiumsInvestments | Accretion (Amortization) of Discounts and Premiums, Investments | USD | 4.44M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | AccruedEmployeeBenefitsCurrent | Accrued Employee Benefits, Current | USD | 315,000 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | AccruedLiabilities | Accrued Liabilities (Deprecated 2009-01-31) | USD | 32,667 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 | |
| us-gaap | AccruedLiabilitiesCurrent | Accrued Liabilities, Current | USD | 187.22M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AccruedProfessionalFeesCurrent | Accrued Professional Fees, Current | USD | 498,000 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001628280-16-015744 | |
| us-gaap | AccruedProfessionalFeesCurrentAndNoncurrent | Accrued Professional Fees | USD | 4.05M | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001628280-16-020847 | |
| us-gaap | AccruedRoyaltiesCurrent | Accrued Royalties, Current | USD | 41.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AccruedSalariesCurrent | Accrued Salaries, Current | USD | 33.93M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment | Accumulated Depreciation, Depletion and Amortization, Property, Plant, and Equipment | USD | 10.10M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | AccumulatedOtherComprehensiveIncomeLossNetOfTax | Accumulated Other Comprehensive Income (Loss), Net of Tax | USD | -2.05M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AdditionalPaidInCapital | Additional Paid in Capital | USD | 1.62B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AdditionalPaidInCapitalCommonStock | Additional Paid in Capital, Common Stock | USD | 1.02B | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 | |
| us-gaap | AdjustmentForAmortization | Amortization | USD | 0 | 2011-03-01 | 2011-08-31 | 2011 | Q2 | 10-Q/A | 2012-06-06 | 0001225279-12-000084 |
| us-gaap | AdjustmentsNoncashItemsToReconcileNetIncomeLossToCashProvidedByUsedInOperatingActivities | Adjustments, Noncash Items, to Reconcile Net Income (Loss) to Cash Provided by (Used in) Operating Activities | USD | 1.36M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalIncomeTaxDeficiencyFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Deficiency from Share-based Compensation | USD | 359,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalOther | Adjustments to Additional Paid in Capital, Other | USD | -98,000 | 2021-04-01 | 2021-06-30 | 2022 | Q2 | 10-Q | 2022-08-04 | 0001438533-22-000032 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationEmployeeStockPurchaseProgramRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, ESPP, Increase for Cost Recognition | USD | 338,000 | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001438533-24-000020 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue | APIC, Share-based Payment Arrangement, Increase for Cost Recognition | USD | 29.86M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationRestrictedStockUnitsRequisiteServicePeriodRecognition | APIC, Share-based Payment Arrangement, Restricted Stock Unit, Increase for Cost Recognition | USD | 771,318 | 2014-01-01 | 2014-03-31 | 2014 | Q1 | 10-Q | 2014-05-15 | 0001193805-14-000998 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalStockIssuedIssuanceCosts | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs | USD | 12.20M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation | USD | 2.42M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | AdjustmentsToAdditionalPaidInCapitalWarrantIssued | Adjustments to Additional Paid in Capital, Warrant Issued | USD | 24.63M | 2023-01-01 | 2023-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium | AdjustmentToAdditionalPaidInCapitalConvertibleDebtInstrumentIssuedAtSubstantialPremium | USD | 91.34M | 2026-01-01 | 2026-06-30 | 2026 | Q2 | 10-Q | 2026-08-04 | 0001438533-26-000063 |
| us-gaap | AdvertisingExpense | Advertising Expense | USD | 14.70M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | AllocatedShareBasedCompensationExpense | Share-based Payment Arrangement, Expense | USD | 61.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | AllowanceForDoubtfulAccountsReceivable | Accounts Receivable, Allowance for Credit Loss | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | AmortizationOfDebtDiscountPremium | Amortization of Debt Discount (Premium) | USD | 382,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | AmortizationOfFinancingCosts | Amortization of Debt Issuance Costs | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | AmortizationOfFinancingCostsAndDiscounts | Amortization of Debt Issuance Costs and Discounts | USD | 1.64M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | AmortizationOfIntangibleAssets | Amortization of Intangible Assets | USD | 33.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount | Antidilutive Securities Excluded from Computation of Earnings Per Share, Amount | shares | 24.26M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | AssetImpairmentCharges | Asset Impairment Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | Assets | Assets | USD | 848.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AssetsCurrent | Assets, Current | USD | 633.45M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AssetsFairValueDisclosure | Assets, Fair Value Disclosure | USD | 471.82M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AssetsOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Assets, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Gain, before Tax | USD | 2,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Debt Securities, Available-for-sale, Accumulated Gross Unrealized Loss, before Tax | USD | 2.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleDebtSecuritiesAmortizedCostBasis | Debt Securities, Available-for-sale, Amortized Cost | USD | 350.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleSecurities | Available-for-sale Securities | USD | 202.94M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Gain, before Tax | USD | 7,000 | 2016-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax | Available-for-sale Securities, Accumulated Gross Unrealized Loss, before Tax | USD | 1.26M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | AvailableForSaleSecuritiesAmortizedCost | Available-for-sale Securities, Amortized Cost Basis | USD | 204.20M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Accumulated Loss | USD | 132,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Fair Value | USD | 77.42M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 132,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionLessThanTwelveMonthsFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Less than Twelve Months, Fair Value | USD | 77.42M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesContinuousUnrealizedLossPositionTwelveMonthsOrLongerFairValue | Available-for-sale Securities, Continuous Unrealized Loss Position, Twelve Months or Longer, Fair Value | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | AvailableForSaleSecuritiesCurrent | Available-for-sale Securities, Current | USD | 166.38M | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecurities | Debt Securities, Available-for-sale | USD | 348.28M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesCurrent | Debt Securities, Available-for-sale, Current | USD | 179.83M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleSecuritiesDebtSecuritiesNoncurrent | Debt Securities, Available-for-sale, Noncurrent | USD | 168.44M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | AvailableForSaleSecuritiesGrossRealizedGainLossNet | Available-for-sale Securities, Gross Realized Gain (Loss) | USD | 100,000 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | BusinessAcquisitionCostOfAcquiredEntityTransactionCosts | Business Acquisition, Transaction Costs | USD | 97.10M | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 | |
| us-gaap | BusinessAcquisitionProFormaEarningsPerShareDiluted | Business Acquisition, Pro Forma Earnings Per Share, Diluted | USD/shares | -2.51 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | BusinessAcquisitionsProFormaNetIncomeLoss | Business Acquisition, Pro Forma Net Income (Loss) | USD | -61.52M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | BusinessAcquisitionsProFormaRevenue | Business Acquisition, Pro Forma Revenue | USD | 6.99M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | BusinessCombinationBargainPurchaseGainRecognizedAmount | Business Combination, Bargain Purchase, Gain Recognized, Amount | USD | 88.50M | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001571049-15-003959 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationAsset1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Asset | USD | 604,000 | 2015-01-01 | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001571049-15-006497 |
| us-gaap | BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1 | Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability | USD | -4.89M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 |
| us-gaap | BusinessCombinationContingentConsiderationLiability | Business Combination, Contingent Consideration, Liability | USD | 74.10M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityCurrent | Business Combination, Contingent Consideration, Liability, Current | USD | 6.90M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 | |
| us-gaap | BusinessCombinationContingentConsiderationLiabilityNoncurrent | Business Combination, Contingent Consideration, Liability, Noncurrent | USD | 67.20M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 | |
| us-gaap | BusinessCombinationLiabilitiesArisingFromContingenciesAmountRecognized | Business Combination, Liabilities Arising from Contingencies, Amount Recognized | USD | 1.50M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedCurrentAssetsPrepaidExpenseAndOtherAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Current Assets, Prepaid Expense and Other Assets | USD | 116,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedIndefiniteLivedIntangibleAssets | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Indefinite-Lived Intangible Assets | USD | 71.37M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | BusinessCombinationRecognizedIdentifiableAssetsAcquiredAndLiabilitiesAssumedInventory | Business Combination, Recognized Identifiable Assets Acquired and Liabilities Assumed, Inventory | USD | 517,000 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | BusinessDevelopment | Business Development | USD | 300,000 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193805-14-000650 |
| us-gaap | CapitalExpendituresIncurredButNotYetPaid | Capital Expenditures Incurred but Not yet Paid | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | Cash | Cash | USD | 6.00M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | CashAcquiredFromAcquisition | Cash Acquired from Acquisition | USD | 3,721 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | CashAndCashEquivalentsAtCarryingValue | Cash and Cash Equivalents, at Carrying Value | USD | 123.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CashAndCashEquivalentsFairValueDisclosure | Cash and Cash Equivalents, Fair Value Disclosure | USD | 123.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CashAndCashEquivalentsPeriodIncreaseDecrease | Cash and Cash Equivalents, Period Increase (Decrease) | USD | 3.48M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | 123.54M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect | USD | 30.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | CashPeriodIncreaseDecrease | Cash, Period Increase (Decrease) | USD | -9 | 2012-03-01 | 2012-11-30 | 2012 | Q3 | 10-Q | 2013-03-06 | 0001193805-13-000588 |
| us-gaap | CashProvidedByUsedInFinancingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Financing Activities, Discontinued Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | CashProvidedByUsedInInvestingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Investing Activities, Discontinued Operations | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | CashProvidedByUsedInOperatingActivitiesDiscontinuedOperations | Cash Provided by (Used in) Operating Activities, Discontinued Operations | USD | 23.50M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ClassOfWarrantOrRightNumberOfSecuritiesCalledByWarrantsOrRights | Class of Warrant or Right, Number of Securities Called by Warrants or Rights | shares | 168,612 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | ClassOfWarrantOrRightOutstanding | Class of Warrant or Right, Outstanding | shares | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 | |
| us-gaap | CommonStockParOrStatedValuePerShare | Common Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CommonStockSharesAuthorized | Common Stock, Shares Authorized | shares | 200.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CommonStockSharesIssued | Common Stock, Shares, Issued | shares | 95.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CommonStockSharesOutstanding | Common Stock, Shares, Outstanding | shares | 95.67M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CommonStockValue | Common Stock, Value, Issued | USD | 9,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | CommonUnitIssued | Common Unit, Issued | shares | 401,047 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | ComprehensiveIncomeNetOfTax | Comprehensive Income (Loss), Net of Tax, Attributable to Parent | USD | -125.09M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ConcentrationRiskPercentage1 | Concentration Risk, Percentage | pure | 0.98 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | ContractualObligation | Contractual Obligation | USD | 100.27M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | ContractualObligationDueAfterFifthYear | Contractual Obligation, to be Paid, after Year Five | USD | 1.15M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | ContractualObligationDueInFifthYear | Contractual Obligation, to be Paid, Year Five | USD | 286,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | ContractualObligationDueInFourthYear | Contractual Obligation, to be Paid, Year Four | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | ContractualObligationDueInNextTwelveMonths | Contractual Obligation, to be Paid, Year One | USD | 50.00M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | ContractualObligationDueInSecondYear | Contractual Obligation, to be Paid, Year Two | USD | 1.56M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | ContractualObligationDueInThirdYear | Contractual Obligation, to be Paid, Year Three | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | ContractWithCustomerLiability | Contract with Customer, Liability | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | ContractWithCustomerLiabilityCurrent | Contract with Customer, Liability, Current | USD | 2.81M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | ContractWithCustomerLiabilityNoncurrent | Contract with Customer, Liability, Noncurrent | USD | 0 | 2024-06-30 | 2024 | Q2 | 10-Q | 2024-08-01 | 0001438533-24-000031 | |
| us-gaap | ContractWithCustomerPerformanceObligationSatisfiedInPreviousPeriod | Contract with Customer, Performance Obligation Satisfied in Previous Period | USD | 1.90M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ConvertibleDebt | Convertible Debt | USD | 603.51M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ConvertibleDebtCurrent | Convertible Debt, Current | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | ConvertibleDebtFairValueDisclosures | Convertible Debt, Fair Value Disclosures | USD | 300.60M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 | |
| us-gaap | ConvertibleDebtNoncurrent | Convertible Debt, Noncurrent | USD | 311.72M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | ConvertibleNotesPayable | Convertible Notes Payable | USD | 25,000 | 2012-05-31 | 2012 | Q1 | 10-Q | 2012-08-08 | 0001225279-12-000193 | |
| us-gaap | ConvertibleNotesPayableCurrent | Convertible Notes Payable, Current | USD | 25.00M | 2011-11-30 | 2011 | Q3 | 10-Q | 2012-01-11 | 0001225279-12-000017 | |
| us-gaap | CostMethodInvestments | Cost Method Investments | USD | 15.00M | 2017-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 | |
| us-gaap | CostOfGoodsAndServicesSold | Cost of Goods and Services Sold | USD | 6.99M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | CostOfGoodsSold | Cost of Goods Sold (Deprecated 2018-01-31) | USD | 2.79M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 |
| us-gaap | CostOfServices | Cost of Services (Deprecated 2018-01-31) | USD | 3,000 | 2012-02-29 | 2012-05-31 | 2012 | Q1 | 10-Q | 2012-08-08 | 0001225279-12-000193 |
| us-gaap | CostsAndExpenses | Costs and Expenses | USD | 622.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | CostsAndExpensesRelatedParty | Costs and Expenses, Related Party | USD | 776 | 2011-03-02 | 2012-02-29 | 2011 | FY | 10-K | 2012-05-24 | 0001225279-12-000073 |
| us-gaap | CumulativeEffectOfNewAccountingPrincipleInPeriodOfAdoption | Cumulative Effect of New Accounting Principle in Period of Adoption (Deprecated 2020-01-31) | USD | 15.71M | 2018-01-01 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 | |
| us-gaap | CurrentFederalTaxExpenseBenefit | Current Federal Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | CurrentForeignTaxExpenseBenefit | Current Foreign Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | CurrentIncomeTaxExpenseBenefit | Current Income Tax Expense (Benefit) | USD | 988,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | CurrentStateAndLocalTaxExpenseBenefit | Current State and Local Tax Expense (Benefit) | USD | 988,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DebtInstrumentAnnualPrincipalPayment | Debt Instrument, Annual Principal Payment | USD | 2.30M | 2013-06-30 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | DebtInstrumentConvertibleThresholdConsecutiveTradingDays1 | Debt Instrument, Convertible, Threshold Consecutive Trading Days | D | 30 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | DebtInstrumentConvertibleThresholdPercentageOfStockPriceTrigger | Debt Instrument, Convertible, Threshold Percentage of Stock Price Trigger | pure | 1.3 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | DebtInstrumentConvertibleThresholdTradingDays | Debt Instrument, Convertible, Threshold Trading Days | D | 20 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | DebtInstrumentInterestRateEffectivePercentage | Debt Instrument, Interest Rate, Effective Percentage | pure | 0.077 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 | |
| us-gaap | DebtInstrumentInterestRateStatedPercentage | Debt Instrument, Interest Rate, Stated Percentage | pure | 0.05 | 2013-06-30 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | DebtInstrumentRepurchaseAmount | Debt Instrument, Repurchase Amount | USD | 23.40M | 2018-09-10 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 | |
| us-gaap | DebtSecuritiesAvailableForSaleAllowanceForCreditLoss | Debt Securities, Available-for-sale, Allowance for Credit Loss | USD | 0 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 | |
| us-gaap | DebtSecuritiesAvailableForSaleAmortizedCostCurrent | Debt Securities, Available-for-sale, Amortized Cost, Current | USD | 400.87M | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLonger | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPosition12MonthsOrLongerAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, 12 Months or Longer, Accumulated Loss | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12Months | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months | USD | 345.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesAvailableForSaleContinuousUnrealizedLossPositionLessThan12MonthsAccumulatedLoss | Debt Securities, Available-for-sale, Continuous Unrealized Loss Position, Less than 12 Months, Accumulated Loss | USD | 2.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesAvailableForSaleRealizedGain | Debt Securities, Available-for-sale, Realized Gain | USD | 100,000 | 2016-01-01 | 2016-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPosition | Debt Securities, Available-for-sale, Unrealized Loss Position | USD | 345.27M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesAvailableForSaleUnrealizedLossPositionAccumulatedLoss | Debt Securities, Available-for-sale, Unrealized Loss Position, Accumulated Loss | USD | 2.24M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | DebtSecuritiesRealizedGainLoss | Debt Securities, Realized Gain (Loss) | USD | 0 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | DebtSecuritiesUnrealizedGainLoss | Debt Securities, Unrealized Gain (Loss) | USD | 100,000 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | DeferredFederalIncomeTaxExpenseBenefit | Deferred Federal Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DeferredFinanceCostsNet | Debt Issuance Costs, Net | USD | 8.80M | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 | |
| us-gaap | DeferredIncomeTaxesAndTaxCredits | Deferred Income Taxes and Tax Credits | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | DeferredIncomeTaxExpenseBenefit | Deferred Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DeferredIncomeTaxLiabilities | Deferred Tax Liabilities, Gross | USD | 3.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredIncomeTaxLiabilitiesNet | Deferred Income Tax Liabilities, Net | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | DeferredStateAndLocalIncomeTaxExpenseBenefit | Deferred State and Local Income Tax Expense (Benefit) | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DeferredTaxAssetInterestCarryforward | Deferred Tax Asset, Interest Carryforward | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | DeferredTaxAssetsCharitableContributionCarryforwards | Deferred Tax Assets, Charitable Contribution Carryforwards | USD | 5.70M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsGoodwillAndIntangibleAssets | Deferred Tax Assets, Goodwill and Intangible Assets | USD | 56.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsGross | Deferred Tax Assets, Gross | USD | 374.04M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsInProcessResearchAndDevelopment | Deferred Tax Assets, in Process Research and Development | USD | 27.17M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNet | Deferred Tax Assets, Net | USD | 4.85M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001438533-17-000034 | |
| us-gaap | DeferredTaxAssetsLiabilitiesNetNoncurrent | Deferred Tax Assets, Net, Noncurrent | USD | 8.69M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001571049-15-006497 | |
| us-gaap | DeferredTaxAssetsNet | Deferred Tax Assets, Net of Valuation Allowance | USD | 0 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsOperatingLossCarryforwards | Deferred Tax Assets, Operating Loss Carryforwards | USD | 130.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsOther | Deferred Tax Assets, Other | USD | 0 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 | |
| us-gaap | DeferredTaxAssetsPropertyPlantAndEquipment | Deferred Tax Assets, Property, Plant and Equipment | USD | 602,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsStateTaxes | Deferred Tax Assets, State Taxes | USD | 2.40M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsTaxCreditCarryforwardsResearch | Deferred Tax Assets, Tax Credit Carryforwards, Research | USD | 112.09M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost | Deferred Tax Assets, Tax Deferred Expense, Compensation and Benefits, Share-based Compensation Cost | USD | 13.97M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsTaxDeferredExpenseReservesAndAccrualsAccruedLiabilities | Deferred Tax Assets, Tax Deferred Expense, Reserves and Accruals, Accrued Liabilities | USD | 21.73M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxAssetsValuationAllowance | Deferred Tax Assets, Valuation Allowance | USD | 370.65M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxLiabilities | Deferred Tax Liabilities, Net | USD | 0 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | DeferredTaxLiabilitiesCurrent | Deferred Tax Liabilities, Net, Current | USD | 15.89M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseDeferredFinancingCosts | Deferred Tax Liabilities, Deferred Expense, Debt Issuance Costs | USD | 9 | 2012-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseOtherCapitalizedCosts | Deferred Tax Liabilities, Deferred Expense, Other Capitalized Costs | USD | -610,000 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | DeferredTaxLiabilitiesDeferredExpenseReservesAndAccruals | Deferred Tax Liabilities, Deferred Expense, Reserves and Accruals | USD | -385 | 2012-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 | |
| us-gaap | DeferredTaxLiabilitiesGoodwillAndIntangibleAssetsIntangibleAssets | Deferred Tax Liabilities, Intangible Assets | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 | |
| us-gaap | DeferredTaxLiabilitiesLeasingArrangements | Deferred Tax Liabilities, Leasing Arrangements | USD | 3.21M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DeferredTaxLiabilitiesNoncurrent | Deferred Tax Liabilities, Net, Noncurrent | USD | 1.19M | 2017-06-30 | 2017 | Q2 | 10-Q | 2017-08-09 | 0001438533-17-000029 | |
| us-gaap | DeferredTaxLiabilitiesPrepaidExpenses | Deferred Tax Liabilities, Prepaid Expenses | USD | 184,000 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | DefinedContributionPlanEmployerDiscretionaryContributionAmount | Defined Contribution Plan, Employer Discretionary Contribution Amount | USD | 2.80M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DepositAssets | Deposit Assets | USD | 2.25M | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | DepositsAssetsNoncurrent | Deposits Assets, Noncurrent | USD | 244,058 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | Depreciation | Depreciation | USD | 1.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | DepreciationAndAmortization | Depreciation, Depletion and Amortization, Nonproduction | USD | 214,785 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | DepreciationDepletionAndAmortization | Depreciation, Depletion and Amortization | USD | 34.65M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | DerivativeGainLossOnDerivativeNet | Derivative, Gain (Loss) on Derivative, Net | USD | -10.10M | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | DerivativeLiabilities | Derivative Liability | USD | 25.04M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | DerivativeLiabilitiesCurrent | Derivative Liability, Current | USD | 15.70M | 2017-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 | |
| us-gaap | DevelopmentStageEnterpriseDeficitAccumulatedDuringDevelopmentStage | Development Stage Enterprise, Deficit Accumulated During Development Stage (Deprecated 2015-01-31) | USD | 129.58M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | DilutiveSecuritiesEffectOnBasicEarningsPerShareOther | Dilutive Securities, Effect on Basic Earnings Per Share, Dilutive Convertible Securities | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | DisposalGroupIncludingDiscontinuedOperationAssetsNoncurrent | Disposal Group, Including Discontinued Operation, Assets, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | DisposalGroupNotDiscontinuedOperationGainLossOnDisposal | Disposal Group, Not Discontinued Operation, Gain (Loss) on Disposal | USD | -7.50M | 2019-01-01 | 2019-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | DueFromAffiliateNoncurrent | Due from Affiliate, Noncurrent | USD | 137,547 | 2012-12-31 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | DueToRelatedParties | Due to Related Parties (Deprecated 2009-01-31) | USD | 9,572 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 | |
| us-gaap | EarningsPerShareBasic | Earnings Per Share, Basic | USD/shares | -1.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | EarningsPerShareBasicAndDiluted | Earnings Per Share, Basic and Diluted | USD/shares | -3.56 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | EarningsPerShareDiluted | Earnings Per Share, Diluted | USD/shares | -1.33 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | EffectiveIncomeTaxRateContinuingOperations | Effective Income Tax Rate Reconciliation, Percent | pure | -0.02 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation, at Federal Statutory Income Tax Rate, Percent | pure | 0.21 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance | Effective Income Tax Rate Reconciliation, Change in Deferred Tax Assets Valuation Allowance, Percent | pure | -0.167 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Percent | pure | -0.118 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseMealsAndEntertainment | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Meals and Entertainment, Percent | pure | 0 | 2011-03-11 | 2011-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Percent | pure | -0.009 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Percent | pure | -0.025 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherAdjustments | Effective Income Tax Rate Reconciliation, Other Adjustments, Percent | pure | 0.008 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationOtherReconcilingItemsPercent | Effective Income Tax Rate Reconciliation,Other Reconciling Items, Percent | pure | -0.009 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationShareBasedCompensationExcessTaxBenefitPercent | Effective Income Tax Rate Reconciliation, Tax Expense (Benefit), Share-based Payment Arrangement, Percent | pure | -0.029 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Percent | pure | -0.014 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Percent | pure | 0.03 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCredits | Effective Income Tax Rate Reconciliation, Tax Credit, Percent | pure | -0.042 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Percent | pure | -0.329 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | EffectiveIncomeTaxRateReconciliationTaxSettlementsDomestic | Effective Income Tax Rate Reconciliation, Tax Settlement, Domestic, Percent | pure | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | EffectOfChangeInCashFlowProjectionEstimate | Effect of Change in Cash Flow Projection Estimate (Deprecated 2013-01-31) | USD | -49 | 2011-03-02 | 2012-02-29 | 2011 | FY | 10-K | 2012-05-24 | 0001225279-12-000073 |
| us-gaap | EffectOfExchangeRateOnCash | Effect of Exchange Rate on Cash | USD | -1,177 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001571049-14-006312 |
| us-gaap | EffectOfExchangeRateOnCashAndCashEquivalents | Effect of Exchange Rate on Cash and Cash Equivalents | USD | -135,000 | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents | Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents | USD | -47,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | EmployeeBenefitsAndShareBasedCompensation | Employee Benefits and Share-based Compensation | USD | 22.13M | 2011-03-11 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | EmployeeRelatedLiabilitiesCurrent | Employee-related Liabilities, Current | USD | 8.16M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | EmployeeRelatedLiabilitiesCurrentAndNoncurrent | Employee-related Liabilities | USD | 1.14M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized | Share-based Payment Arrangement, Nonvested Award, Cost Not yet Recognized, Amount | USD | 1.29M | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions | Share-based Payment Arrangement, Nonvested Award, Option, Cost Not yet Recognized, Amount | USD | 1.11M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | EquityMethodInvestments | Equity Method Investments | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | ExcessTaxBenefitFromShareBasedCompensationFinancingActivities | Excess Tax Benefit from Share-based Compensation, Financing Activities | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | FairValueAdjustmentOfWarrants | Fair Value Adjustment of Warrants | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | FairValueAssumptionsExercisePrice | Fair Value Assumptions, Exercise Price (Deprecated 2018-01-31) | USD | 12.76 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | FairValueAssumptionsExpectedDividendRate | Fair Value Assumptions, Expected Dividend Rate (Deprecated 2018-01-31) | pure | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | FairValueAssumptionsExpectedVolatilityRate | Fair Value Assumptions, Expected Volatility Rate (Deprecated 2018-01-31) | pure | 0.85 | 2014-01-01 | 2014-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | FairValueAssumptionsRiskFreeInterestRate | Fair Value Assumptions, Risk Free Interest Rate (Deprecated 2018-01-31) | pure | 0.014 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | FairValueEstimateNotPracticableSecuritiesSoldNotYetPurchased | Fair Value, Estimate Not Practicable, Securities Sold, Not yet Purchased (Deprecated 2018-01-31) | USD | 1.46M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisLiabilitySettlements | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability, Settlements | USD | 2.76M | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 |
| us-gaap | FairValueMeasurementWithUnobservableInputsReconciliationsRecurringBasisLiabilityValue | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Liability Value | USD | 74.10M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 | |
| us-gaap | FiniteLivedIntangibleAssetsAccumulatedAmortization | Finite-Lived Intangible Assets, Accumulated Amortization | USD | 213.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive | Finite-Lived Intangible Asset, Expected Amortization, after Year Five | USD | 30.05M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths | Finite-Lived Intangible Asset, Expected Amortization, Year One | USD | 31.48M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFive | Finite-Lived Intangible Asset, Expected Amortization, Year Five | USD | 12.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearFour | Finite-Lived Intangible Asset, Expected Amortization, Year Four | USD | 12.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearThree | Finite-Lived Intangible Asset, Expected Amortization, Year Three | USD | 12.92M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo | Finite-Lived Intangible Asset, Expected Amortization, Year Two | USD | 12.89M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | FiniteLivedIntangibleAssetsGross | Finite-Lived Intangible Assets, Gross | USD | 377.12M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | FiniteLivedIntangibleAssetsNet | Finite-Lived Intangible Assets, Net | USD | 163.35M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | FiniteLivedPatentsGross | Finite-Lived Patents, Gross | USD | 49,775 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | ForeignCurrencyTransactionGainBeforeTax | Foreign Currency Transaction Gain, before Tax | USD | 500,000 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 |
| us-gaap | ForeignCurrencyTransactionGainLossBeforeTax | Foreign Currency Transaction Gain (Loss), before Tax | USD | -1.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ForeignCurrencyTransactionGainLossRealized | Foreign Currency Transaction Gain (Loss), Realized | USD | 4.08M | 2022-01-01 | 2022-09-30 | 2022 | Q3 | 10-Q | 2022-10-27 | 0001438533-22-000051 |
| us-gaap | GainLossOnDispositionOfAssets1 | Gain (Loss) on Disposition of Assets | USD | 0 | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 |
| us-gaap | GainLossOnSaleOfPropertyPlantEquipment | Gain (Loss) on Disposition of Property Plant Equipment | USD | -62,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | GainLossOnSalesOfAssetsAndAssetImpairmentCharges | Gain (Loss) on Sale of Assets and Asset Impairment Charges | USD | 204,198 | 2015-01-01 | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001571049-15-003959 |
| us-gaap | GainLossRelatedToLitigationSettlement | Gain (Loss) Related to Litigation Settlement | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | GainsLossesOnExtinguishmentOfDebt | Gain (Loss) on Extinguishment of Debt | USD | -7.60M | 2022-03-11 | 2025 | Q2 | 10-Q | 2025-08-06 | 0001438533-25-000046 | |
| us-gaap | GeneralAndAdministrativeExpense | General and Administrative Expense | USD | 9,170 | 2012-03-01 | 2012-11-30 | 2012 | Q3 | 10-Q | 2013-03-06 | 0001193805-13-000588 |
| us-gaap | Goodwill | Goodwill | USD | 800,000 | 2025-09-30 | 2025 | Q3 | 10-Q | 2025-10-30 | 0001438533-25-000056 | |
| us-gaap | GoodwillImpairmentLoss | Goodwill, Impairment Loss | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 |
| us-gaap | ImpairmentOfIntangibleAssetsExcludingGoodwill | Impairment of Intangible Assets (Excluding Goodwill) | USD | 0 | 2023-01-01 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 |
| us-gaap | ImpairmentOfIntangibleAssetsFinitelived | Impairment of Intangible Assets, Finite-lived | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | ImpairmentOfRetainedInterest | Impairment of Retained Interest | USD | 0 | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | IncentiveToLessee | Incentive to Lessee | USD | 7.90M | 2020-12-31 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 | |
| us-gaap | IncomeLossFromContinuingOperations | Income (Loss) from Continuing Operations, Net of Tax, Attributable to Parent | USD | -132.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic | Income (Loss) from Continuing Operations before Income Taxes, Domestic | USD | -7,009 | 2012-02-29 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 |
| us-gaap | IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest | Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest | USD | -138.66M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromContinuingOperationsPerBasicShare | Income (Loss) from Continuing Operations, Per Basic Share | USD/shares | -1.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromContinuingOperationsPerDilutedShare | Income (Loss) from Continuing Operations, Per Diluted Share | USD/shares | -1.42 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxAttributableToReportingEntity | Income (Loss) from Discontinued Operations, Net of Tax, Attributable to Parent | USD | 8.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicAndDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic and Diluted Share | USD/shares | -0.03 | 2012-02-29 | 2012-05-31 | 2012 | Q1 | 10-Q | 2012-08-08 | 0001225279-12-000193 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerBasicShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Basic Share | USD/shares | 0.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeLossFromDiscontinuedOperationsNetOfTaxPerDilutedShare | Income (Loss) from Discontinued Operations and Disposal of Discontinued Operations, Net of Tax, Per Diluted Share | USD/shares | 0.09 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeTaxesPaid | Income Taxes Paid | USD | 656,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | IncomeTaxesPaidNet | Income Taxes Paid, Net | USD | 453,000 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 |
| us-gaap | IncomeTaxesReceivable | Income Taxes Receivable, Current | USD | 247,000 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestAccrued | Income Tax Examination, Penalties and Interest Accrued | USD | 0 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 | |
| us-gaap | IncomeTaxExaminationPenaltiesAndInterestExpense | Income Tax Examination, Penalties and Interest Expense | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxExpenseBenefit | Income Tax Expense (Benefit) | USD | -6.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncomeTaxReceivable | Income Taxes Receivable | USD | 405,000 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 | |
| us-gaap | IncomeTaxReconciliationForeignIncomeTaxRateDifferential | Effective Income Tax Rate Reconciliation, Foreign Income Tax Rate Differential, Amount | USD | 5.83M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate | Effective Income Tax Rate Reconciliation at Federal Statutory Income Tax Rate, Amount | USD | -10.35M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseOther | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Other, Amount | USD | 442,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost | Effective Income Tax Rate Reconciliation, Nondeductible Expense, Share-based Payment Arrangement, Amount | USD | 1.25M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationStateAndLocalIncomeTaxes | Effective Income Tax Rate Reconciliation, State and Local Income Taxes, Amount | USD | 701,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationTaxContingencies | Effective Income Tax Rate Reconciliation, Tax Contingency, Amount | USD | -1.46M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncomeTaxReconciliationTaxCreditsResearch | Effective Income Tax Rate Reconciliation, Tax Credit, Research, Amount | USD | 16.22M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncreaseDecreaseDueFromOtherRelatedParties | Increase (Decrease) Due from Other Related Parties | USD | 0 | 2011-03-11 | 2013-03-31 | 2013 | Q1 | 10-Q/A | 2013-09-16 | 0001193805-13-001601 |
| us-gaap | IncreaseDecreaseInAccountsPayable | Increase (Decrease) in Accounts Payable | USD | 2.31M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | IncreaseDecreaseInAccountsPayableAndAccruedLiabilities | Increase (Decrease) in Accounts Payable and Accrued Liabilities | USD | -3.52M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInAccountsReceivable | Increase (Decrease) in Accounts Receivable | USD | 42.51M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInAccruedIncomeTaxesPayable | Increase (Decrease) in Income Taxes Payable | USD | -181,000 | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-05 | 0001438533-17-000017 |
| us-gaap | IncreaseDecreaseInAccruedLiabilities | Increase (Decrease) in Accrued Liabilities | USD | 2.47M | 2011-03-11 | 2012-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 |
| us-gaap | IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities | Increase (Decrease) in Accrued Liabilities and Other Operating Liabilities | USD | 44.55M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInContractWithCustomerLiability | Increase (Decrease) in Contract with Customer, Liability | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInDeferredIncomeTaxes | Increase (Decrease) in Deferred Income Taxes | USD | 75,775 | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193805-14-000650 |
| us-gaap | IncreaseDecreaseInDueFromRelatedParties | Increase (Decrease) in Due from Related Parties | USD | 137,547 | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | IncreaseDecreaseInDueToRelatedParties | Increase (Decrease) in Due to Related Parties | USD | -2,800 | 2012-01-01 | 2012-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | IncreaseDecreaseInIncomeTaxes | Increase (Decrease) in Income Taxes | USD | 75,775 | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | IncreaseDecreaseInIncomeTaxesReceivable | Increase (Decrease) in Income Taxes Receivable | USD | -849,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | IncreaseDecreaseInInventories | Increase (Decrease) in Inventories | USD | 6.05M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInLeaseAcquisitionCosts | Increase (Decrease) in Lease Acquisition Costs | USD | -301,244 | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | IncreaseDecreaseInOperatingLiabilities | Increase (Decrease) in Operating Liabilities | USD | 200,000 | 2014-01-01 | 2014-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 |
| us-gaap | IncreaseDecreaseInOtherCurrentAssets | Increase (Decrease) in Other Current Assets | USD | 8,781 | 2012-01-01 | 2012-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | IncreaseDecreaseInOtherCurrentLiabilities | Increase (Decrease) in Other Current Liabilities | USD | 1.69M | 2011-03-11 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | IncreaseDecreaseInOtherOperatingAssets | Increase (Decrease) in Other Operating Assets | USD | 2.04M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 |
| us-gaap | IncreaseDecreaseInOtherOperatingCapitalNet | Increase (Decrease) in Other Operating Assets and Liabilities, Net | USD | -21,830 | 2011-03-11 | 2012-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 |
| us-gaap | IncreaseDecreaseInOtherOperatingLiabilities | Increase (Decrease) in Other Operating Liabilities | USD | -2.03M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets | Increase (Decrease) in Prepaid Expense and Other Assets | USD | 12.47M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncreaseDecreaseInPrepaidExpense | Increase (Decrease) in Prepaid Expense | USD | 480,647 | 2011-03-11 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | IncreaseDecreaseInPrepaidTaxes | Increase (Decrease) in Prepaid Taxes | USD | -555,000 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | IncreaseDecreaseInSecurityDeposits | Increase (Decrease) in Security Deposits | USD | -92,956 | 2014-01-01 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001571049-14-006312 |
| us-gaap | IncreaseInRestrictedCash | Increase in Restricted Cash | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | IncrementalCommonSharesAttributableToCallOptionsAndWarrants | Incremental Common Shares Attributable to Dilutive Effect of Call Options and Warrants | shares | 0 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 |
| us-gaap | IncrementalCommonSharesAttributableToConversionOfDebtSecurities | Incremental Common Shares Attributable to Dilutive Effect of Conversion of Debt Securities | shares | 11.39M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | IncrementalCommonSharesAttributableToShareBasedPaymentArrangements | Incremental Common Shares Attributable to Dilutive Effect of Share-based Payment Arrangements | shares | 39.16M | 2017-01-01 | 2017-03-31 | 2017 | Q1 | 10-Q | 2017-05-05 | 0001438533-17-000017 |
| us-gaap | IndefiniteLivedIntangibleAssetsExcludingGoodwill | Indefinite-lived Intangible Assets (Excluding Goodwill) | USD | 10.56M | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | InducedConversionOfConvertibleDebtExpense | Induced Conversion of Convertible Debt Expense | USD | 40.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | InsuranceSettlementsReceivable | Insurance Settlements Receivable | USD | 562,500 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 | |
| us-gaap | IntangibleAssetsGrossExcludingGoodwill | Intangible Assets, Gross (Excluding Goodwill) | USD | 245.80M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 | |
| us-gaap | IntangibleAssetsNetExcludingGoodwill | Intangible Assets, Net (Excluding Goodwill) | USD | 164.11M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InterestAndOtherIncome | Interest and Other Income | USD | -21,905 | 2011-03-11 | 2013-03-31 | 2013 | Q1 | 10-Q/A | 2013-09-16 | 0001193805-13-001601 |
| us-gaap | InterestExpense | Interest Expense | USD | 2.80M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001438533-24-000020 |
| us-gaap | InterestExpenseNonoperating | InterestExpenseNonoperating | USD | 6.58M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | InterestIncomeExpenseNet | Interest Income (Expense), Net | USD | 1.76M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 |
| us-gaap | InterestIncomeExpenseNonoperatingNet | Interest Income (Expense), Nonoperating, Net | USD | -2.80M | 2024-01-01 | 2024-03-31 | 2024 | Q1 | 10-Q | 2024-05-06 | 0001438533-24-000020 |
| us-gaap | InterestOnConvertibleDebtNetOfTax | Interest on Convertible Debt, Net of Tax | USD | 2.56M | 2025-07-01 | 2025-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | InterestPaid | Interest Paid, Including Capitalized Interest, Operating and Investing Activities | USD | 2.07M | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | InterestPaidNet | Interest Paid, Excluding Capitalized Interest, Operating Activities | USD | 8.84M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | InterestPayableCurrent | Interest Payable, Current | USD | 776,000 | 2016-03-31 | 2016 | Q1 | 10-Q | 2016-05-05 | 0001628280-16-015744 | |
| us-gaap | InterestReceivableCurrent | Interest Receivable, Current | USD | 2.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryFinishedGoods | Inventory, Finished Goods, Gross | USD | 368,940 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001571049-14-006312 | |
| us-gaap | InventoryFinishedGoodsNetOfReserves | Inventory, Finished Goods, Net of Reserves | USD | 12.66M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryGross | Inventory, Gross | USD | 10.52M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryLIFOReservePeriodCharge | Inventory, LIFO Reserve, Period Charge | USD | 816,000 | 2018-01-01 | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 |
| us-gaap | InventoryNet | Inventory, Net | USD | 43.80M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryNoncurrent | Inventory, Noncurrent | USD | 33.29M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryRawMaterials | Inventory, Raw Materials, Gross | USD | 314,625 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001571049-14-006312 | |
| us-gaap | InventoryRawMaterialsNetOfReserves | Inventory, Raw Materials, Net of Reserves | USD | 18.77M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryValuationReserves | Inventory Valuation Reserves | USD | 3.70M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | InventoryWorkInProcessNetOfReserves | Inventory, Work in Process, Net of Reserves | USD | 12.38M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | InventoryWriteDown | Inventory Write-down | USD | 684,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | InvestmentIncomeInterest | Investment Income, Interest | USD | 9.64M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | InvestmentsAndOtherNoncurrentAssets | Investments and Other Noncurrent Assets | USD | 400,000 | 2014-09-30 | 2014 | Q3 | 10-Q | 2014-11-13 | 0001571049-14-006312 | |
| us-gaap | InvestmentSoldNotYetPurchasedSaleProceeds | Investment Sold, Not yet Purchased, Sale Proceeds | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 |
| us-gaap | LaborAndRelatedExpense | Labor and Related Expense | USD | 24.73M | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | LandSubjectToGroundLeases | Land Subject to Ground Leases | sqft | 4,216 | 2012-08-31 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | LeaseAndRentalExpense | Operating Leases, Rent Expense | USD | 275,000 | 2012-08-01 | 2012-08-31 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | LeaseIncentiveReceivable | Lease Incentive Receivable | USD | 7.90M | 2020-12-31 | 2021 | Q2 | 10-Q | 2021-07-29 | 0001438533-21-000034 | |
| us-gaap | LegalFees | Legal Fees | USD | 0 | 2018-07-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001438533-18-000032 |
| us-gaap | LesseeOperatingLeaseDiscountRate | Lessee, Operating Lease, Discount Rate | pure | 0.077 | 2020-02-07 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001438533-20-000011 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDue | Lessee, Operating Lease, Liability, to be Paid | USD | 13.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive | Lessee, Operating Lease, Liability, to be Paid, after Year Five | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths | Lessee, Operating Lease, Liability, to be Paid, Year One | USD | 6.98M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFive | Lessee, Operating Lease, Liability, to be Paid, Year Five | USD | 4.78M | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearFour | Lessee, Operating Lease, Liability, to be Paid, Year Four | USD | 4.78M | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearThree | Lessee, Operating Lease, Liability, to be Paid, Year Three | USD | 4.78M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsDueYearTwo | Lessee, Operating Lease, Liability, to be Paid, Year Two | USD | 4.78M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear | Lessee, Operating Lease, Liability, to be Paid, Remainder of Fiscal Year | USD | 1.70M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LesseeOperatingLeaseLiabilityUndiscountedExcessAmount | Lessee, Operating Lease, Liability, Undiscounted Excess Amount | USD | 818,000 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | Liabilities | Liabilities | USD | 825.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LiabilitiesAndStockholdersEquity | Liabilities and Equity | USD | 848.23M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LiabilitiesCurrent | Liabilities, Current | USD | 210.91M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | LiabilitiesFairValueDisclosure | Financial and Nonfinancial Liabilities, Fair Value Disclosure | USD | 74.10M | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationCurrent | Disposal Group, Including Discontinued Operation, Liabilities, Current | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | LiabilitiesOfDisposalGroupIncludingDiscontinuedOperationNoncurrent | Disposal Group, Including Discontinued Operation, Liabilities, Noncurrent | USD | 0 | 2023-12-31 | 2023 | FY | 10-K | 2024-02-20 | 0001438533-24-000005 | |
| us-gaap | LitigationSettlementExpense | Litigation Settlement, Expense | USD | 0 | 2019-01-01 | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | LongTermDebt | Long-term Debt | USD | 46.00M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtAndCapitalLeaseObligations | Long-term Debt and Lease Obligation | USD | 22.60M | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001438533-18-000032 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFive | Long-Term Debt, Maturity, after Year Five | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths | Long-Term Debt, Maturity, Year One | USD | 45.00M | 2015-06-30 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001571049-15-006497 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFive | Long-Term Debt, Maturity, Year Five | USD | 46.00M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour | Long-Term Debt, Maturity, Year Four | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree | Long-Term Debt, Maturity, Year Three | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo | Long-Term Debt, Maturity, Year Two | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear | Long-Term Debt, Maturity, Remainder of Fiscal Year | USD | 0 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | LongTermNotesPayable | Notes Payable, Noncurrent | USD | 40.80M | 2015-03-31 | 2015 | Q1 | 10-Q | 2015-05-11 | 0001571049-15-003959 | |
| us-gaap | LongTermPurchaseCommitmentAmount | Long-term Purchase Commitment, Amount | USD | 22.10M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001438533-23-000048 |
| us-gaap | LossContingencyDamagesSoughtValue | Loss Contingency, Damages Sought, Value | USD | 2.00M | 2015-06-01 | 2015-06-19 | 2015 | Q2 | 10-Q | 2015-08-10 | 0001571049-15-006497 |
| us-gaap | MarketableSecurities | Marketable Securities | USD | 289.44M | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001438533-20-000011 | |
| us-gaap | MarketableSecuritiesRealizedGainLoss | Marketable Securities, Realized Gain (Loss) | USD | 374,482 | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | MarketableSecuritiesRealizedGainLossExcludingOtherThanTemporaryImpairments | Marketable Securities, Realized Gain (Loss), Excluding Other-than-temporary Impairment Loss | USD | 8,000 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | MarketableSecuritiesUnrealizedGainLoss | Marketable Securities, Unrealized Gain (Loss) | USD | -4.39M | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 |
| us-gaap | NetCashProvidedByUsedInFinancingActivities | Net Cash Provided by (Used in) Financing Activities | USD | 219.01M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetCashProvidedByUsedInFinancingActivitiesContinuingOperations | Net Cash Provided by (Used in) Financing Activities, Continuing Operations | USD | -33.47M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | NetCashProvidedByUsedInInvestingActivities | Net Cash Provided by (Used in) Investing Activities | USD | -304.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetCashProvidedByUsedInInvestingActivitiesContinuingOperations | Net Cash Provided by (Used in) Investing Activities, Continuing Operations | USD | 27.89M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | NetCashProvidedByUsedInOperatingActivities | Net Cash Provided by (Used in) Operating Activities | USD | 115.91M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetCashProvidedByUsedInOperatingActivitiesContinuingOperations | Net Cash Provided by (Used in) Operating Activities, Continuing Operations | USD | 92.41M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLoss | Net Income (Loss) Attributable to Parent | USD | -124.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossAttributableToParentDiluted | Net Income (Loss) Attributable to Parent, Diluted | USD | -102.68M | 2018-01-01 | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersBasic | Net Income (Loss) Available to Common Stockholders, Basic | USD | -124.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossAvailableToCommonStockholdersDiluted | Net Income (Loss) Available to Common Stockholders, Diluted | USD | -124.24M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersBasic | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Basic | USD | -132.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossFromContinuingOperationsAvailableToCommonShareholdersDiluted | Net Income (Loss) from Continuing Operations Available to Common Shareholders, Diluted | USD | -132.44M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersBasic | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Basic | USD | 8.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NetIncomeLossFromDiscontinuedOperationsAvailableToCommonShareholdersDiluted | Net Income (Loss) from Discontinued Operations Available to Common Shareholders, Diluted | USD | 8.20M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NonoperatingIncomeExpense | Nonoperating Income (Expense) | USD | -37.59M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NotesAndLoansReceivableNetCurrent | Financing Receivable, after Allowance for Credit Loss, Current | USD | 0 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | NotesAndLoansReceivableNetNoncurrent | Financing Receivable, after Allowance for Credit Loss, Noncurrent | USD | 0 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 | |
| us-gaap | NotesPayableCurrent | Notes Payable, Current | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | NotesPayableRelatedPartiesClassifiedCurrent | Notes Payable, Related Parties, Current | USD | 884,764 | 2012-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | NotesPayableRelatedPartiesCurrentAndNoncurrent | Notes Payable, Related Parties | USD | 884,764 | 2012-12-31 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | NotesReceivableRelatedParties | Notes Receivable, Related Parties | USD | 200,000 | 2012-02-03 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | NumberOfBusinessesAcquired | Number of Businesses Acquired | business | 2 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 |
| us-gaap | NumberOfOperatingSegments | Number of Operating Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NumberOfReportableSegments | Number of Reportable Segments | segment | 1 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | NumberOfReportingUnits | Number of Reporting Units | reporting_unit | 1 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | OperatingExpenses | Operating Expenses | USD | 62.84M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001438533-20-000011 |
| us-gaap | OperatingIncomeLoss | Operating Income (Loss) | USD | -101.07M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OperatingLeaseExpense | Operating Lease, Expense | USD | 3.30M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OperatingLeaseLiability | Operating Lease, Liability | USD | 12.64M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OperatingLeaseLiabilityCurrent | Operating Lease, Liability, Current | USD | 6.31M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OperatingLeaseLiabilityNoncurrent | Operating Lease, Liability, Noncurrent | USD | 6.33M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OperatingLeasePayments | Operating Lease, Payments | USD | 6.58M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | OperatingLeaseRightOfUseAsset | Operating Lease, Right-of-Use Asset | USD | 7.81M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OperatingLeaseRightOfUseAssetAmortizationExpense | Operating Lease, Right-of-Use Asset, Amortization Expense | USD | 1.21M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDue | Operating Leases, Future Minimum Payments Due | USD | 14.03M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueCurrent | Operating Leases, Future Minimum Payments Due, Next Twelve Months | USD | 2.34M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFiveYears | Operating Leases, Future Minimum Payments, Due in Five Years | USD | 2.64M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInFourYears | Operating Leases, Future Minimum Payments, Due in Four Years | USD | 2.56M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingAfterYearFive | Operating Leases, Future Minimum Payments, Due in Rolling after Year Five | USD | 4.22M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearFourAndFive | Operating Leases, Future Minimum Payments, Due in Rolling Year Four and Five | USD | 5.05M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInRollingYearTwoAndThree | Operating Leases, Future Minimum Payments, Due in Rolling Year Two and Three | USD | 4.76M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInThreeYears | Operating Leases, Future Minimum Payments, Due in Three Years | USD | 2.49M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueInTwoYears | Operating Leases, Future Minimum Payments, Due in Two Years | USD | 2.41M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsDueThereafter | Operating Leases, Future Minimum Payments, Due Thereafter | USD | 1.58M | 2018-12-31 | 2018 | FY | 10-K | 2019-02-26 | 0001438533-19-000003 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsNextRollingTwelveMonths | Operating Leases, Future Minimum Payments, Next Rolling Twelve Months | USD | 2.01M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | OperatingLeasesFutureMinimumPaymentsRemainderOfFiscalYear | Operating Leases, Future Minimum Payments, Remainder of Fiscal Year | USD | 138,200 | 2012-12-31 | 2012 | FY | 10-K/A | 2013-09-16 | 0001193805-13-001600 | |
| us-gaap | OperatingLeaseWeightedAverageDiscountRatePercent | Operating Lease, Weighted Average Discount Rate, Percent | pure | 0.065 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OtherAccruedLiabilitiesCurrent | Other Accrued Liabilities, Current | USD | 187,000 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | OtherAccruedLiabilitiesNoncurrent | Other Accrued Liabilities, Noncurrent | USD | 29,667 | 2011-02-28 | 2011 | Q2 | 10-Q/A | 2012-06-06 | 0001225279-12-000084 | |
| us-gaap | OtherAssets | Other Assets | USD | 1.93M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | OtherAssetsCurrent | Other Assets, Current | USD | 134,457 | 2013-03-31 | 2013 | Q1 | 10-Q/A | 2013-09-16 | 0001193805-13-001601 | |
| us-gaap | OtherAssetsNoncurrent | Other Assets, Noncurrent | USD | 6.86M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OtherCommitment | Other Commitment | USD | 4.52M | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | OtherCommitmentDueAfterFifthYear | Other Commitment, to be Paid, after Year Five | USD | 1.15M | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherCommitmentDueInFifthYear | Other Commitment, to be Paid, Year Five | USD | 286,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherCommitmentDueInFourthYear | Other Commitment, to be Paid, Year Four | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherCommitmentDueInNextTwelveMonths | Other Commitment, to be Paid, Year One | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherCommitmentDueInSecondYear | Other Commitment, to be Paid, Year Two | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherCommitmentDueInThirdYear | Other Commitment, to be Paid, Year Three | USD | 436,980 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | OtherComprehensiveIncomeAvailableforsaleSecuritiesAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Available-for-sale Securities Adjustment, Net of Tax, Portion Attributable to Parent | USD | -2.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OtherComprehensiveIncomeDefinedBenefitPlansAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive (Income) Loss, Defined Benefit Plan, after Tax and Reclassification Adjustment, Attributable to Parent | USD | -219,000 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent | Other Comprehensive Income (Loss), Foreign Currency Transaction and Translation Adjustment, Net of Tax, Portion Attributable to Parent | USD | 1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OtherComprehensiveIncomeLossAvailableForSaleSecuritiesAdjustmentNetOfTax | OCI, Debt Securities, Available-for-Sale, Gain (Loss), after Adjustment and Tax | USD | -2.22M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OtherComprehensiveIncomeLossNetOfTax | Other Comprehensive Income (Loss), Net of Tax | USD | -0.07 | 2012-02-29 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 |
| us-gaap | OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIForSaleOfSecuritiesNetOfTax | Other Comprehensive Income (Loss), Reclassification Adjustment from AOCI for Sale of Securities, Net of Tax | USD | 300,000 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | OtherExpenses | Other Expenses | USD | 8.99M | 2011-03-11 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | OtherIntangibleAssetsNet | Other Intangible Assets, Net | USD | 9.80M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | OtherLiabilities | Other Liabilities | USD | 12.78M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | OtherLiabilitiesCurrent | Other Liabilities, Current | USD | 2.10M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OtherLiabilitiesNoncurrent | Other Liabilities, Noncurrent | USD | 4.89M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | OtherNoncashExpense | Other Noncash Expense | USD | 0 | 2015-01-01 | 2015-09-30 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 |
| us-gaap | OtherNoncashIncomeExpense | Other Noncash Income (Expense) | USD | 3.62M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OtherNoninterestExpense | Other Noninterest Expense | USD | 8.39M | 2011-03-11 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | OtherNonoperatingIncomeExpense | Other Nonoperating Income (Expense) | USD | -650,000 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | OtherReceivablesNetCurrent | Other Receivables, Net, Current | USD | 5.96M | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 | |
| us-gaap | OtherSignificantNoncashTransactionValueOfConsiderationGiven1 | Other Significant Noncash Transaction, Value of Consideration Given | USD | 42.01M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | PaymentForContingentConsiderationLiabilityFinancingActivities | Payment for Contingent Consideration Liability, Financing Activities | USD | 863,000 | 2023-01-01 | 2023-06-30 | 2023 | Q2 | 10-Q | 2023-08-03 | 0001438533-23-000039 |
| us-gaap | PaymentOfFinancingAndStockIssuanceCosts | Payment of Financing and Stock Issuance Costs | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | PaymentsForProceedsFromOtherInvestingActivities | Payments for (Proceeds from) Other Investing Activities | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | PaymentsForRepurchaseOfCommonStock | Payments for Repurchase of Common Stock | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | PaymentsForRestructuring | Payments for Restructuring | USD | 12.93M | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | PaymentsOfDebtIssuanceCosts | Payments of Debt Issuance Costs | USD | 16.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | PaymentsOfStockIssuanceCosts | Payments of Stock Issuance Costs | USD | 0 | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001628280-16-020847 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecurities | Payments to Acquire Available-for-sale Securities | USD | 29.52M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 |
| us-gaap | PaymentsToAcquireAvailableForSaleSecuritiesDebt | Payments to Acquire Debt Securities, Available-for-sale | USD | 381.30M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001438533-23-000048 |
| us-gaap | PaymentsToAcquireBusinessesGross | Payments to Acquire Businesses, Gross | USD | 500,000 | 2016-06-01 | 2016-06-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001438533-20-000031 |
| us-gaap | PaymentsToAcquireBusinessesNetOfCashAcquired | Payments to Acquire Businesses, Net of Cash Acquired | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | PaymentsToAcquireEquityMethodInvestments | Payments to Acquire Equity Method Investments | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | PaymentsToAcquireIntangibleAssets | Payments to Acquire Intangible Assets | USD | 72.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | PaymentsToAcquireInvestments | Payments to Acquire Investments | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | PaymentsToAcquireMarketableSecurities | Payments to Acquire Marketable Securities | USD | 283.31M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | PaymentsToAcquirePropertyPlantAndEquipment | Payments to Acquire Property, Plant, and Equipment | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | PreferredStockParOrStatedValuePerShare | Preferred Stock, Par or Stated Value Per Share | USD/shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PreferredStockSharesAuthorized | Preferred Stock, Shares Authorized | shares | 20.00M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PreferredStockSharesIssued | Preferred Stock, Shares Issued | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PreferredStockSharesOutstanding | Preferred Stock, Shares Outstanding | shares | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PreferredStockValue | Preferred Stock, Value, Issued | USD | 0 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PrepaidExpense | Prepaid Expense (Deprecated 2009-01-31) | USD | 0 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 | |
| us-gaap | PrepaidExpenseAndOtherAssetsCurrent | Prepaid Expense and Other Assets, Current | USD | 43.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | PrepaidTaxes | Prepaid Taxes | USD | 1.40M | 2019-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 | |
| us-gaap | ProceedsFromConvertibleDebt | Proceeds from Convertible Debt | USD | 525.00M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ProceedsFromIssuanceOfCommonStock | Proceeds from Issuance of Common Stock | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | ProceedsFromIssuanceOfLongTermDebt | Proceeds from Issuance of Long-term Debt | USD | 42.92M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | ProceedsFromIssuanceOfOtherLongTermDebt | Proceeds from Issuance of Other Long-term Debt | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | ProceedsFromIssuanceOfPreferredStockPreferenceStockAndWarrants | Proceeds from Issuance of Preferred Stock, Preference Stock, and Warrants | USD | 5.41M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193805-14-000650 |
| us-gaap | ProceedsFromIssuanceOfPrivatePlacement | Proceeds from Issuance of Private Placement | USD | 30.90M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans | Proceeds, Issuance of Shares, Share-based Payment Arrangement, Excluding Option Exercised | USD | 2.11M | 2021-01-01 | 2021-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | ProceedsFromIssuanceOfWarrants | Proceeds from Issuance of Warrants | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | ProceedsFromLinesOfCredit | Proceeds from Lines of Credit | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | ProceedsFromMaturitiesPrepaymentsAndCallsOfAvailableForSaleSecurities | Proceeds from Maturities, Prepayments and Calls of Debt Securities, Available-for-sale | USD | 284.60M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001438533-23-000048 |
| us-gaap | ProceedsFromNotesPayable | Proceeds from Notes Payable | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | ProceedsFromPaymentsForOtherFinancingActivities | Proceeds from (Payments for) Other Financing Activities | USD | 2.05M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | ProceedsFromRelatedPartyDebt | Proceeds from Related Party Debt | USD | 10,500 | 2012-01-01 | 2012-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities | Proceeds from Sale and Maturity of Debt Securities, Available-for-sale | USD | 164.06M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ProceedsFromSaleAndMaturityOfMarketableSecurities | Proceeds from Sale and Maturity of Marketable Securities | USD | 382.00M | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecurities | Proceeds from Sale of Available-for-sale Securities | USD | 63.56M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 |
| us-gaap | ProceedsFromSaleOfAvailableForSaleSecuritiesDebt | Proceeds from Sale of Debt Securities, Available-for-sale | USD | 49.15M | 2020-01-01 | 2020-03-31 | 2020 | Q1 | 10-Q | 2020-05-11 | 0001438533-20-000011 |
| us-gaap | ProceedsFromSaleOfIntangibleAssets | Proceeds from Sale of Intangible Assets | USD | 47.50M | 2017-01-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001438533-17-000034 |
| us-gaap | ProceedsFromSaleOfProductiveAssets | Proceeds from Sale of Productive Assets | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | ProceedsFromStockOptionsExercised | Proceeds from Stock Options Exercised | USD | 60.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ProceedsFromStockPlans | Proceeds from Stock Plans | USD | 2.36M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ProceedsFromWarrantExercises | Proceeds from Warrant Exercises | USD | 4.30M | 2018-01-01 | 2018-09-30 | 2019 | Q3 | 10-Q | 2019-10-30 | 0001438533-19-000036 |
| us-gaap | ProfessionalFees | Professional Fees | USD | 12,500 | 2014-01-01 | 2014-01-14 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ProfitLoss | Net Income (Loss), Including Portion Attributable to Noncontrolling Interest | USD | -62.14M | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | PropertyPlantAndEquipmentGross | Property, Plant and Equipment, Gross | USD | 14.12M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | PropertyPlantAndEquipmentNet | Property, Plant and Equipment, Net | USD | 2.72M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ProvisionForDoubtfulAccounts | Accounts Receivable, Credit Loss Expense (Reversal) | USD | 100,000 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | PurchaseObligation | Purchase Obligation | USD | 8.12M | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | RelatedPartyTransactionDueFromToRelatedParty | Related Party Transaction, Due from (to) Related Party | USD | 6,000 | 2012-08-31 | 2012 | Q2 | 10-Q | 2012-10-10 | 0001225279-12-000219 | |
| us-gaap | RepaymentsOfConvertibleDebt | Repayments of Convertible Debt | USD | 0 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | RepaymentsOfLinesOfCredit | Repayments of Lines of Credit | USD | 0 | 2017-01-01 | 2017-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | RepaymentsOfLongTermDebt | Repayments of Long-term Debt | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | RepaymentsOfNotesPayable | Repayments of Notes Payable | USD | 0 | 2016-01-01 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 |
| us-gaap | RepaymentsOfOtherDebt | Repayments of Other Debt | USD | 0 | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | RepaymentsOfRelatedPartyDebt | Repayments of Related Party Debt | USD | 0 | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | RepaymentsOfSecuredDebt | Repayments of Secured Debt | USD | 900,000 | 2013-01-01 | 2013-03-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | ResearchAndDevelopmentExpense | Research and Development Expense | USD | 7.50M | 2023-01-01 | 2023-09-30 | 2023 | Q3 | 10-Q | 2023-11-07 | 0001438533-23-000048 |
| us-gaap | ResearchAndDevelopmentExpenseExcludingAcquiredInProcessCost | Research and Development Expense (Excluding Acquired in Process Cost) | USD | 187.68M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ResearchAndDevelopmentInProcess | Research and Development in Process | USD | 0 | 2022-01-01 | 2022-12-31 | 2022 | FY | 10-K | 2023-02-23 | 0001438533-23-000008 |
| us-gaap | RestrictedCashAndCashEquivalents | Restricted Cash and Cash Equivalents | USD | 40,000 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 | |
| us-gaap | RestrictedCashAndCashEquivalentsNoncurrent | Restricted Cash and Cash Equivalents, Noncurrent | USD | 40,000 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | RestructuringAndRelatedCostCostIncurredToDate1 | Restructuring and Related Cost, Cost Incurred to Date | USD | 13.80M | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | RestructuringAndRelatedCostExpectedCostRemaining1 | Restructuring and Related Cost, Expected Cost Remaining | USD | 1.40M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001438533-17-000034 | |
| us-gaap | RestructuringCharges | Restructuring Charges | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | RestructuringCosts | Restructuring Costs | USD | 12.40M | 2023-12-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001438533-24-000048 |
| us-gaap | RestructuringReserve | Restructuring Reserve | USD | 0 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | RestructuringReserveAccrualAdjustment1 | Restructuring Reserve, Accrual Adjustment | USD | 200,000 | 2018-01-01 | 2018-12-31 | 2019 | FY | 10-K | 2020-02-24 | 0001438533-20-000004 |
| us-gaap | RestructuringReserveCurrent | Restructuring Reserve, Current | USD | 0 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | RestructuringReserveTranslationAdjustment | Restructuring Reserve, Foreign Currency Translation Gain (Loss) | USD | -74,000 | 2024-01-01 | 2024-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | RetainedEarningsAccumulatedDeficit | Retained Earnings (Accumulated Deficit) | USD | -1.60B | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | RevenueFromContractWithCustomerExcludingAssessedTax | Revenue from Contract with Customer, Excluding Assessed Tax | USD | 521.35M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | Revenues | Revenues | USD | 0 | 2012-03-01 | 2012-11-30 | 2012 | Q3 | 10-Q | 2013-03-06 | 0001193805-13-000588 |
| us-gaap | RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability | Right-of-Use Asset Obtained in Exchange for Operating Lease Liability | USD | 34.61M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | RoyaltyExpense | Royalty Expense | USD | 39.85M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | SaleOfStockNumberOfSharesIssuedInTransaction | Sale of Stock, Number of Shares Issued in Transaction | shares | 7.50M | 2020-06-01 | 2020-06-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001438533-20-000031 |
| us-gaap | SaleOfStockPricePerShare | Sale of Stock, Price Per Share | USD/shares | 15.5 | 2020-06-30 | 2020 | Q3 | 10-Q | 2020-11-05 | 0001438533-20-000031 | |
| us-gaap | SalesRevenueGoodsNet | Sales Revenue, Goods, Net (Deprecated 2018-01-31) | USD | 79.77M | 2018-01-01 | 2018-06-30 | 2018 | Q2 | 10-Q | 2018-08-03 | 0001438533-18-000028 |
| us-gaap | SecurityDeposit | Security Deposit | USD | 177,547 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | SellingGeneralAndAdministrativeExpense | Selling, General and Administrative Expense | USD | 274.78M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | SettlementLiabilitiesCurrent | Settlement Liabilities, Current | USD | 1.69M | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 | |
| us-gaap | ShareBasedCompensation | Share-based Payment Arrangement, Noncash Expense | USD | 61.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardAcceleratedCompensationCost | Share-based Payment Arrangement, Accelerated Cost | USD | 8.50M | 2011-03-11 | 2013-09-30 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 6.24 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedNumber | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Number | shares | 268,642 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | USD/shares | 6.44 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period | shares | 275,793 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Vested in Period, Weighted Average Grant Date Fair Value | USD/shares | 5.44 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Dividend Rate | pure | 0 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Expected Volatility Rate | pure | 0.85 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate | Share-based Compensation Arrangement by Share-based Payment Award, Fair Value Assumptions, Risk Free Interest Rate | pure | 0.016 | 2014-01-01 | 2014-06-30 | 2014 | Q2 | 10-Q | 2014-08-14 | 0001193805-14-001682 |
| us-gaap | SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1 | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Intrinsic Value | USD | 154.46M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Number | shares | 4.01M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercisable, Weighted Average Exercise Price | USD/shares | 20.37 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period, Intrinsic Value | USD | 90.72M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period | shares | 103,494 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price | USD/shares | 22.41 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Intrinsic Value | USD/shares | 4 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Gross | shares | 1.37M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Grants in Period, Weighted Average Grant Date Fair Value | USD/shares | 6.03 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Intrinsic Value | USD | 238.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Number | shares | 6.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Outstanding, Weighted Average Exercise Price | USD/shares | 22.56 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Aggregate Intrinsic Value | USD | 238.84M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Number | shares | 6.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice | Share-based Compensation Arrangement by Share-based Payment Award, Options, Vested and Expected to Vest, Outstanding, Weighted Average Exercise Price | USD/shares | 22.56 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationIncrementalCompensationCost | Share-based Payment Arrangement, Plan Modification, Incremental Cost | USD | 4.40M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Exercises in Period, Weighted Average Exercise Price | USD/shares | 20.61 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice | Share-based Compensation Arrangements by Share-based Payment Award, Options, Grants in Period, Weighted Average Exercise Price | USD/shares | 34.26 | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | SharePrice | Share Price | USD/shares | 17.42 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 | |
| us-gaap | SharesIssuedPricePerShare | Shares Issued, Price Per Share | USD/shares | 19 | 2015-03-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 | |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensation | Shares Granted, Value, Share-based Payment Arrangement, after Forfeiture | USD | 2.49M | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K | 2014-03-28 | 0001193805-14-000650 |
| us-gaap | StockGrantedDuringPeriodValueSharebasedCompensationGross | Shares Granted, Value, Share-based Payment Arrangement, before Forfeiture | USD | 60.46M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | StockholdersEquity | Stockholders' Equity Attributable to Parent | USD | 22.58M | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest | USD | 283.76M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | StockholdersEquityIncludingPortionAttributableToNoncontrollingInterestAdjustedBalance1 | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Adjusted Balance (Deprecated 2020-01-31) | USD | 299.48M | 2018-03-31 | 2018 | Q1 | 10-Q | 2018-07-06 | 0001438533-18-000022 | |
| us-gaap | StockIssued1 | Stock Issued | USD | 4.72M | 2014-01-01 | 2014-12-31 | 2014 | FY | 10-K | 2015-03-11 | 0001571049-15-001817 |
| us-gaap | StockIssuedDuringPeriodSharesConversionOfConvertibleSecurities | Stock Issued During Period, Shares, Conversion of Convertible Securities | shares | 1.25M | 2024-07-01 | 2024-09-30 | 2024 | Q3 | 10-Q | 2024-10-31 | 0001438533-24-000048 |
| us-gaap | StockIssuedDuringPeriodSharesEmployeeStockPurchasePlans | Stock Issued During Period, Shares, Employee Stock Purchase Plans | shares | 0 | 2026-07-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | StockIssuedDuringPeriodSharesNewIssues | Stock Issued During Period, Shares, New Issues | shares | 7.87M | 2015-03-24 | 2015 | Q3 | 10-Q | 2015-11-06 | 0001628280-15-008436 | |
| us-gaap | StockIssuedDuringPeriodSharesStockOptionsExercised | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period | shares | 2.93M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | StockIssuedDuringPeriodValueAcquisitions | Stock Issued During Period, Value, Acquisitions | USD | 15.84M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | StockIssuedDuringPeriodValueConversionOfConvertibleSecurities | Stock Issued During Period, Value, Conversion of Convertible Securities | USD | 22.59M | 2019-01-01 | 2019-12-31 | 2021 | FY | 10-K | 2022-02-24 | 0001438533-22-000008 |
| us-gaap | StockIssuedDuringPeriodValueEmployeeStockPurchasePlan | Stock Issued During Period, Value, Employee Stock Purchase Plan | USD | 3.83M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | StockIssuedDuringPeriodValueIssuedForServices | Stock Issued During Period, Value, Issued for Services | USD | 4.40M | 2012-01-01 | 2012-12-31 | 2013 | Q3 | 10-Q/A | 2015-07-09 | 0001571049-15-005545 |
| us-gaap | StockIssuedDuringPeriodValueNewIssues | Stock Issued During Period, Value, New Issues | USD | 194.16M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 |
| us-gaap | StockIssuedDuringPeriodValueShareBasedCompensation | Shares Issued, Value, Share-based Payment Arrangement, after Forfeiture | USD | 59.89M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | StockIssuedDuringPeriodValueStockOptionsExercised | Stock Issued During Period, Value, Stock Options Exercised | USD | 6.82M | 2015-01-01 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 |
| us-gaap | StockOptionPlanExpense | Stock or Unit Option Plan Expense | USD | 345,000 | 2019-01-01 | 2019-06-30 | 2019 | Q2 | 10-Q | 2019-08-06 | 0001438533-19-000024 |
| us-gaap | StockRepurchasedDuringPeriodShares | Stock Repurchased During Period, Shares | shares | 130,790 | 2013-01-01 | 2013-12-31 | 2013 | FY | 10-K/A | 2015-07-09 | 0001571049-15-005546 |
| us-gaap | StockRepurchasedDuringPeriodValue | Stock Repurchased During Period, Value | USD | 3.20M | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | TaxCreditCarryforwardAmount | Tax Credit Carryforward, Amount | USD | 61,000 | 2016-12-31 | 2016 | FY | 10-K | 2017-03-01 | 0001438533-17-000005 | |
| us-gaap | TaxesPayableCurrent | Taxes Payable, Current | USD | 1.15M | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001438533-17-000034 | |
| us-gaap | TemporaryEquityForeignCurrencyTranslationAdjustments | Temporary Equity, Foreign Currency Translation Adjustments | USD | 1.09M | 2021-01-01 | 2021-09-30 | 2021 | Q3 | 10-Q | 2021-10-29 | 0001438533-21-000053 |
| us-gaap | TreasuryStockRetiredParValueMethodAmount | Treasury Stock, Retired, Par Value Method, Amount | USD | 0 | 2015-01-01 | 2015-12-31 | 2017 | FY | 10-K | 2018-07-06 | 0001438533-18-000020 |
| us-gaap | TreasuryStockShares | Treasury Stock, Shares | shares | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | TreasuryStockValue | Treasury Stock, Value | USD | 0 | 2015-12-31 | 2015 | FY | 10-K | 2016-02-26 | 0001628280-16-011857 | |
| us-gaap | UnrecognizedTaxBenefits | Unrecognized Tax Benefits | USD | 26.03M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Decrease Resulting from Prior Period Tax Positions | USD | 4.72M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | UnrecognizedTaxBenefitsDecreasesResultingFromSettlementsWithTaxingAuthorities | Unrecognized Tax Benefits, Decrease Resulting from Settlements with Taxing Authorities | USD | 0 | 2024-01-01 | 2024-12-31 | 2024 | FY | 10-K | 2025-02-21 | 0001438533-25-000010 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense | Unrecognized Tax Benefits, Income Tax Penalties and Interest Expense | USD | 0 | 2017-07-01 | 2017-09-30 | 2017 | Q3 | 10-Q | 2017-11-07 | 0001438533-17-000034 |
| us-gaap | UnrecognizedTaxBenefitsIncomeTaxPenaltiesExpense | Unrecognized Tax Benefits, Income Tax Penalties Expense | USD | 0 | 2018-01-01 | 2018-09-30 | 2018 | Q3 | 10-Q | 2018-11-01 | 0001438533-18-000032 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Current Period Tax Positions | USD | 3.34M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions | Unrecognized Tax Benefits, Increase Resulting from Prior Period Tax Positions | USD | 0 | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | UnrecognizedTaxBenefitsPeriodIncreaseDecrease | Unrecognized Tax Benefits, Period Increase (Decrease) | USD | -1.80M | 2016-01-01 | 2016-09-30 | 2016 | Q3 | 10-Q | 2016-11-04 | 0001628280-16-020847 |
| us-gaap | UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate | Unrecognized Tax Benefits that Would Impact Effective Tax Rate | USD | 26.00M | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 | |
| us-gaap | ValuationAllowanceDeferredTaxAssetChangeInAmount | Valuation Allowance, Deferred Tax Asset, Increase (Decrease), Amount | USD | 26.50M | 2025-01-01 | 2025-12-31 | 2025 | FY | 10-K | 2026-02-19 | 0001438533-26-000014 |
| us-gaap | WeightedAverageNumberOfDilutedSharesOutstanding | Weighted Average Number of Shares Outstanding, Diluted | shares | 93.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | WeightedAverageNumberOfShareOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted | shares | 47.54M | 2020-01-01 | 2020-12-31 | 2020 | FY | 10-K | 2021-03-01 | 0001438533-21-000008 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasic | Weighted Average Number of Shares Outstanding, Basic | shares | 93.34M | 2026-01-01 | 2026-09-30 | 2026 | Q3 | 10-Q | 2026-11-02 | 0001438533-26-000077 |
| us-gaap | WeightedAverageNumberOfSharesOutstandingBasicAndDiluted | Weighted Average Number of Shares Outstanding, Basic and Diluted (Deprecated 2012-01-31) | shares | 959,127 | 2011-08-31 | 2011 | Q2 | 10-Q/A | 2012-06-06 | 0001225279-12-000084 | |
| us-gaap | WriteOffOfDeferredDebtIssuanceCost | Write off of Deferred Debt Issuance Cost | USD | 3.40M | 2022-03-11 | 2025 | Q2 | 10-Q | 2025-08-06 | 0001438533-25-000046 |